Utestående aksjer | 116,227,275 shares |
Innsideraksjer | 25 418 866 shares |
Eierandel blant insidere | 21,87 % |
Totale insidere | 42 |
Insider Sentiment Score
Insider Sentiment Score finner selskapene som blir kjøpt av bedriftsinsidere.
Det er resultatet av en sofistikert, flerfaktor kvantitativ modell som identifiserer selskaper som har de høyeste nivåene av insiderakkumulasjon. Scoringsmodellen bruker en kombinasjon av netto antall insidere som kjøper de siste 90 dagene, det totale antallet kjøpte aksjer som en prosentandel av flyten, og det totale antallet aksjer eid av insidere. Tallet varierer fra 0 til 100, hvor høyere tall indikerer en høyere grad av akkumulasjon sammenlignet med jevnaldrende, og 50 er gjennomsnittet.
Oppdateringsfrekvens: Daglig
Se Insidernes Topp Picks, som gir en liste over selskaper med høyest akkumulasjon blant insidere.
Officer Sentiment Score
Officer Sentiment Score finner selskaper som kjøpes av bedriftsoffiserer.
Per definisjon er Corporate Officers Corporate Insiders, men i motsetning til noen av de andre innsiderne (10 % aksjonærer og styremedlemmer), jobber offiserer for selskapet på daglig basis, og de bruker sine egne penger når de handler . (10 % aksjonærer og styremedlemmer er ofte fondsforvaltere som forvalter andres penger.) Som sådan er innsidehandler utført av offiserer mye mer betydningsfulle og bør behandles på riktig måte.
Som Insider Sentiment Score er Officer Sentiment Score resultatet av en sofistikert, flerfaktor kvantitativ modell som identifiserer selskaper med de høyeste nivåene av akkumulasjon blant ledelsen.
Oppdateringsfrekvens: Daglig
Se Insidernes Topp Picks, som gir en liste over selskaper med høyest insider-sentiment.
Nøkkelindikatorer for insidere
Dette kortet viser hvordan selskapet rangerer langs ulike indikatorer for insidere. Percentile-rangeringen viser hvordan dette selskapet sammenligner seg med andre selskaper på USAs markeder. Høyere rangeringer indikerer bedre situasjoner.
For eksempel, er det generelt akseptert at insiderkjøp er en positiv indikator, så derfor ville selskaper som insiderkjøper mer, rangere høyere enn selskaper med mindre insiderkjøp (eller til og med insidersalg).
Prosent av aksjeflyt kjøpt av insidere (rang)
0.000 %( )
5150 out of 11227Prosenten av aksjeflyt kjøpt av innsidere er det totale antallet aksjer som er blitt kjøpt av innsidere minus det totale antallet aksjer solgt av innsidere de siste 90 dagene, delt på totalt antall utestående aksjer og multiplisert med 100.
Diagram over innsidehandel
Coherus Oncology, Inc. insiderhandel vises i følgende diagram. Innsidere er ledere, direktører eller viktige investorer i et selskap. Generelt sett er det ulovlig for insidere å handle med aksjer i sine selskaper basert på materiell, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre any handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via en Form 4.
Insiderliste og lønnsomhetsmålinger
Denne tabellen viser listen over kjente insidere, og er automatisk generert fra arkiveringer offentliggjort av SEC. I tillegg til navn, siste tittel og direktør-, offiser- eller 10 % eier-betegnelse, gir vi de nyeste offentliggjorte beholdningene. I tillegg gir vi, når det er mulig, den historiske handelsytelsen for insidere. Den historiske handelsytelsen er et vektet gjennomsnitt av ytelsen til faktiske kjøpstransaksjoner som er gjort av insidere på det åpne markedet. For mer informasjon om hvordan dette blir beregnet, kan du se dette YouTube-webinaret.
See our leaderboard of most profitable insider traders.
Innsider | Gjennomsnittlig fortjeneste (%) | Aksjer eid |
Splitt justert |
---|---|---|---|
Vincent R Anicetti Chief Operating Officer - [O] | 124 790 | 124 790 | |
Sankyo Company, LTD Daiichi - | 2 867 426 | 2 867 426 | |
Barbara K Finck Chief Medical Officer - [O] | 37 043 | 37 043 | |
FMR LLC / Fidelity Management & Research - | 361 594 | 361 594 | |
Management Pte Ltd Fullerton
10% Owner -
|
14 762 232 | 14 762 232 | |
James Healy Director - [D] | 0 | 0 | |
Herman Alan C. Chief Scientific Officer - [O] | 50 460 | 50 460 | |
KKR & Co. L.P.
10% Owner -
|
2 499 499 | 2 499 499 | |
KKR Biosimilar GP LLC
10% Owner -
|
2 499 499 | 2 499 499 | |
KKR Biosimilar L.P.
10% Owner -
|
2 499 499 | 2 499 499 | |
KKR Fund Holdings GP Ltd
10% Owner -
|
2 499 499 | 2 499 499 | |
KKR Fund Holdings L.P.
10% Owner -
|
2 499 499 | 2 499 499 | |
KKR Group Holdings L.P.
10% Owner -
|
2 499 499 | 2 499 499 | |
Group Ltd KKR
10% Owner -
|
2 499 499 | 2 499 499 |
Innsider | Gjennomsnittlig fortjeneste (%) | Aksjer eid |
Splitt justert |
---|---|---|---|
KKR Management LLC
10% Owner -
|
2 499 499 | 2 499 499 | |
Henry R Kravis
10% Owner -
|
2 499 499 | 2 499 499 | |
V Bryan Lawlis | 20 000 | ||
Eli & Co Lilly - | 3 042 019 | 3 042 019 | |
Dennis M Lanfear President & CEO, Director - [D] [O] | 1 204 723 | 1 204 723 | |
Lilly Ventures Fund I LLC
10% Owner -
|
3 042 019 | 3 042 019 | |
Alan C Mendelson Director - [D] | 2 569 | 2 569 | |
Bryan J McMichael Chief Financial Officer - [O] | 22 951 | 22 951 | |
Samuel R Md Nussbaum | 20 000 | ||
Lee Nisley Newcomer | 54 000 | ||
Newton Charles W. | 54 000 | ||
Jill O'Donnell-Tormey | 54 000 | ||
George R Roberts
10% Owner -
|
2 499 499 | 2 499 499 | |
Paul Reider Chief Commercial Officer - [O] | 82 069 | 82 069 |
Innsider | Gjennomsnittlig fortjeneste (%) | Aksjer eid |
Splitt justert |
---|---|---|---|
Christos Richards Director - [D] | 63 836 | 63 836 | |
Mark Stolper Director - [D] | 8 800 | 8 800 | |
Satvat Ali J. | 20 000 | ||
McDavid Stilwell Chief Financial Officer - [O] | 75 305 | 75 305 | |
Mary T Szela Director - [D] | 0 | 0 | |
Kimberly Jo Tzoumakas | 27 000 | ||
Temasek Holdings (Private) Ltd
10% Owner -
|
14 762 232 | 14 762 232 | |
Temasek Life Sciences Private Ltd
10% Owner -
|
14 762 232 | 14 762 232 | |
Troendle August J. Director - [D] | 29 994 | 29 994 | |
V-Sciences Investments Pte Ltd
10% Owner -
|
14 762 232 | 14 762 232 | |
Vladimir Vexler Chief Scientific Officer - [O] | 116 361 | 116 361 | |
Jean-Frederic Viret Chief Financial Officer - [O] | 61 295 | 61 295 | |
Mats Wahlstrom Director - [D] | 0 | 0 | |
Watler Peter K. Chief Technical Officer - [O] | 5 900 | 5 900 |
Report errors via our new Insider Auditing Tool
Analyse av sporrekord for insiderkjøp - Kortsiktig lønnsomhetsanalyse
I denne seksjonen analyserer vi lønnsomheten til hver ikke-planlagte, åpne markeds innsidekjøp gjort i CHRS / Coherus Oncology, Inc.. Denne analysen hjelper til med å forstå om insidere konsekvent genererer unormale avkastninger og er verdt å følge. Denne analysen gjelder for ett år etter hver handel, og resultatene er teoretiske .
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en automatisk handelsplan.
Justert pris er prisen justert for splitt. Justerte aksjer er aksjer justert for splitt.
Analyse av sporrekord for insidesalg - Kortsiktig tapanalyse
I denne seksjonen analyserer vi kortsiktig tap til hver ikke-planlagte, åpne markeds innsidekjøp gjort i CHRS / Coherus Oncology, Inc.. Et konsekvent mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder for ett år etter hver handel, og resultatene er teoretiske .
Følgende tabell viser de mest nylige åpne markedssalgene som ikke var en del av en automatisk trading plan.
Justert pris er prisen justert for splitt. Justerte aksjer er aksjer justert for splitt.
Transaksjonshistorikk
Klikk på lenkeikonet for å se hele transaksjonshistorikken. Transaksjoner rapportert som en del av en automatisk handelsplan 10b5-1 vil ha en X i kolonnen merket 10b-5.
Fil dato |
Handels dato |
Skjema | Innsider | Ticker | Verdipapirnavn | Kode | Direkte | Utøvelses pris |
Enhets pris |
Enheter endret |
Verdi endret (1K) |
Gjenværende Opsjoner |
Gjenværende Aksjer |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-05-28 | 2025-05-23 | 4 | Wahlstrom Mats Leonard Capital, LLC | CHRS | Common Stock | I | 0,7389 | −99 988 | −74 | 0 | ||||
2025-01-22 | 2025-01-20 | 4 | McMichael Bryan J | CHRS | Common Stock | D | 1,3900 | −1 711 | −2 | 22 951 | ||||
2025-01-22 | 2025-01-20 | 4 | Reider Paul | CHRS | Common Stock | D | 1,3900 | −4 858 | −7 | 82 069 | ||||
2025-01-22 | 2025-01-20 | 4 | Lanfear Dennis M | CHRS | Common Stock | D | 1,3900 | −11 810 | −16 | 685 074 | ||||
2025-01-10 | 2025-01-07 | 4 | McMichael Bryan J | CHRS | Common Stock | D | 1,5700 | −1 711 | −3 | 24 662 | ||||
2025-01-07 | 2025-01-04 | 4 | Lanfear Dennis M | CHRS | Common Stock | D | 1,6600 | −11 810 | −20 | 696 884 | ||||
2025-01-07 | 2025-01-04 | 4 | Reider Paul | CHRS | Common Stock | D | 1,6600 | −2 277 | −4 | 86 927 | ||||
2024-12-17 | 2024-12-13 | 4 | Reider Paul | CHRS | Common Stock | D | 1,6100 | −2 073 | −3 | 89 204 | ||||
2024-02-15 | 2024-02-09 | 4 | Wahlstrom Mats Leonard Capital, LLC | CHRS | Common Stock | I | 99 988 | 99 988 | ||||||
2024-02-15 | 2024-02-09 | 4 | Wahlstrom Mats | CHRS | Common Stock | D | −99 988 | 0 | ||||||
2024-02-05 | 2024-02-01 | 4 | Wahlstrom Mats | CHRS | Common Stock | D | 1,6670 | 44 991 | 75 | 99 988 | ||||
2024-02-05 | 2024-02-01 | 4 | Wahlstrom Mats | CHRS | Common Stock | D | 1,6670 | 14 997 | 25 | 54 997 | ||||
2024-01-23 | 2024-01-20 | 4 | Lanfear Dennis M | CHRS | Common Stock | D | 2,4400 | −11 218 | −27 | 708 694 | ||||
2024-01-23 | 2024-01-20 | 4 | Reider Paul | CHRS | Common Stock | D | 2,4400 | −4 854 | −12 | 81 277 | ||||
2024-01-23 | 2024-01-20 | 4 | McMichael Bryan J | CHRS | Common Stock | D | 2,4400 | −1 707 | −4 | 22 972 | ||||
2024-01-09 | 2024-01-07 | 4 | McMichael Bryan J | CHRS | Common Stock | D | 2,8700 | −1 707 | −5 | 24 679 | ||||
2024-01-08 | 2024-01-04 | 4 | Lanfear Dennis M | CHRS | Common Stock | D | 2,9200 | −11 781 | −34 | 719 912 | ||||
2024-01-08 | 2024-01-04 | 4 | Reider Paul | CHRS | Common Stock | D | 2,9200 | −2 275 | −7 | 86 131 | ||||
2024-01-03 | 2023-12-31 | 4 | Stilwell McDavid | CHRS | Common Stock | D | 3,3300 | −18 440 | −61 | 75 305 | ||||
2023-12-15 | 2023-12-13 | 4 | Reider Paul | CHRS | Common Stock | D | 2,3700 | −2 049 | −5 | 88 406 | ||||
2023-11-24 | 2023-11-22 | 4 | Lanfear Dennis M | CHRS | Common Stock | D | 2,0160 | −223 100 | −450 | 731 693 | ||||
2023-11-24 | 2023-11-22 | 4 | Lanfear Dennis M | CHRS | Common Stock | D | 1,4170 | 258 940 | 367 | 954 793 | ||||
2023-11-24 | 2023-11-22 | 4 | Lanfear Dennis M | CHRS | Common Stock | D | 1,4170 | 41 000 | 58 | 695 853 | ||||
2023-04-04 | 2023-03-31 | 4 | Vexler Vladimir | CHRS | Common Stock | D | 6,8400 | −16 278 | −111 | 116 361 | ||||
2023-04-04 | 2023-04-01 | 4 | Reider Paul | CHRS | Common Stock | D | 6,8400 | −2 451 | −17 | 87 053 | ||||
2023-04-04 | 2023-04-01 | 4 | Stilwell McDavid | CHRS | Common Stock | D | 6,8400 | −3 457 | −24 | 102 252 | ||||
2023-03-28 | 3 | Reider Paul | CHRS | Common Stock | D | 89 504 | ||||||||
2023-01-24 | 2023-01-20 | 4 | McMichael Bryan J | CHRS | Common Stock | D | 12 500 | 26 386 | ||||||
2023-01-24 | 2023-01-20 | 4 | Stilwell McDavid | CHRS | Common Stock | D | 40 000 | 104 243 | ||||||
2023-01-24 | 2023-01-20 | 4 | Vexler Vladimir | CHRS | Common Stock | D | 40 000 | 131 323 | ||||||
2023-01-24 | 2023-01-20 | 4 | Lanfear Dennis M | CHRS | Common Stock | D | 86 250 | 654 853 | ||||||
2023-01-12 | 2023-01-11 | 4 | Vexler Vladimir | CHRS | Common Stock | D | 10,2600 | −3 602 | −37 | 91 323 | ||||
2023-01-12 | 2023-01-10 | 4 | Vexler Vladimir | CHRS | Common Stock | D | 9,8500 | −3 602 | −35 | 94 925 | ||||
2023-01-10 | 2023-01-07 | 4 | McMichael Bryan J | CHRS | Common Stock | D | 9,5800 | −1 699 | −16 | 13 886 | ||||
2023-01-06 | 2023-01-04 | 4 | Lanfear Dennis M | CHRS | Common Stock | D | 9,8700 | −10 905 | −108 | 568 603 | ||||
2023-01-06 | 2023-01-04 | 4 | Vexler Vladimir | CHRS | Common Stock | D | 9,8700 | −5 437 | −54 | 98 527 | ||||
2023-01-06 | 2023-01-04 | 4 | Stilwell McDavid | CHRS | Common Stock | D | 9,8700 | −5 437 | −54 | 64 243 | ||||
2023-01-04 | 2022-12-30 | 4 | Lanfear Dennis M By Trust | CHRS | Common Stock | I | −4 000 | 432 684 | ||||||
2022-09-09 | 3 | McMichael Bryan J | CHRS | Common Stock | D | 15 584 | ||||||||
2022-05-20 | 2022-05-18 | 4 | O'Donnell-Tormey Jill | CHRS | Stock Option (Right to Buy) | D | 7,45 | 54 000 | 54 000 | |||||
2022-05-06 | 2022-05-04 | 4 | Newton Charles W. | CHRS | Stock Option (Right to Buy) | D | 9,72 | 54 000 | 54 000 | |||||
2022-04-05 | 2022-04-01 | 4 | Vexler Vladimir | CHRS | Common Stock | D | 12,8500 | −3 458 | −44 | 103 963 | ||||
2022-04-05 | 2022-04-01 | 4 | Stilwell McDavid | CHRS | Common Stock | D | 12,8500 | −3 458 | −44 | 69 680 | ||||
2022-03-01 | 2022-02-28 | 4 | Wahlstrom Mats | CHRS | Stock Option (Right to Buy) | D | 2,08 | 29 994 | 0 | |||||
2022-03-01 | 2022-02-28 | 4 | Wahlstrom Mats | CHRS | Common Stock | D | 2,0838 | 29 994 | 63 | 40 000 | ||||
2022-03-01 | 2022-02-25 | 4 | Wahlstrom Mats | CHRS | Common Stock | D | 11,6363 | 10 006 | 116 | 10 006 | ||||
2022-02-11 | 2022-01-07 | 4/A | STOLPER MARK | CHRS | Stock Option (Right to Buy) | D | 14,67 | 27 000 | 27 000 | |||||
2022-02-11 | 2022-01-07 | 4/A | HEALY JAMES | CHRS | Stock Option (Right to Buy) | D | 14,67 | 27 000 | 27 000 | |||||
2022-02-11 | 2022-01-07 | 4/A | Wahlstrom Mats | CHRS | Stock Option (Right to Buy) | D | 14,67 | 27 000 | 27 000 | |||||
2022-02-11 | 2022-01-07 | 4/A | TZOUMAKAS KIMBERLY JO | CHRS | Stock Option (Right to Buy) | D | 14,67 | 27 000 | 27 000 | |||||
2022-02-04 | 2022-02-02 | 4 | Newcomer Lee Nisley | CHRS | Stock Option (Right to Buy) | D | 12,44 | 54 000 | 54 000 | |||||
2022-01-12 | 2022-01-11 | 4 | Vexler Vladimir | CHRS | Common Stock | D | 14,3600 | −3 583 | −51 | 107 421 | ||||
2022-01-12 | 2022-01-10 | 4 | Vexler Vladimir | CHRS | Common Stock | D | 14,3000 | −4 150 | −59 | 111 004 | ||||
2022-01-10 | 2022-01-07 | 4 | STOLPER MARK | CHRS | Stock Option (Right to Buy) | D | 15,94 | 27 000 | 27 000 | |||||
2022-01-10 | 2022-01-07 | 4 | HEALY JAMES | CHRS | Stock Option (Right to Buy) | D | 15,94 | 27 000 | 27 000 | |||||
2022-01-10 | 2022-01-07 | 4 | TZOUMAKAS KIMBERLY JO | CHRS | Stock Option (Right to Buy) | D | 15,94 | 27 000 | 27 000 | |||||
2022-01-10 | 2022-01-07 | 4 | Wahlstrom Mats | CHRS | Stock Option (Right to Buy) | D | 15,94 | 27 000 | 27 000 | |||||
2022-01-06 | 2022-01-04 | 4 | Stilwell McDavid | CHRS | Stock Option (Right to Buy) | D | 15,94 | 80 000 | 80 000 | |||||
2022-01-06 | 2022-01-04 | 4 | Stilwell McDavid | CHRS | Common Stock | D | 40 000 | 73 138 | ||||||
2022-01-06 | 2022-01-04 | 4 | Lanfear Dennis M | CHRS | Stock Option (Right to Buy) | D | 15,94 | 402 500 | 402 500 | |||||
2022-01-06 | 2022-01-04 | 4 | Lanfear Dennis M | CHRS | Common Stock | D | 86 250 | 579 508 | ||||||
2022-01-06 | 2022-01-04 | 4 | Vexler Vladimir | CHRS | Stock Option (Right to Buy) | D | 15,94 | 80 000 | 80 000 | |||||
2022-01-06 | 2022-01-04 | 4 | Vexler Vladimir | CHRS | Common Stock | D | 40 000 | 115 154 | ||||||
2021-11-23 | 2021-11-17 | 4 | Lanfear Dennis M By Trust | CHRS | Common Stock | I | −10 000 | 436 684 | ||||||
2021-10-19 | 2021-10-15 | 4 | Stilwell McDavid | CHRS | Common Stock | D | 16,8003 | −3 507 | −59 | 31 611 | ||||
2021-09-29 | 2021-09-29 | 4 | HEALY JAMES | CHRS | Common Stock, $0.0001 par value | I | 16,1200 | −286 076 | −4 612 | 0 | ||||
2021-09-29 | 2021-09-28 | 4 | HEALY JAMES | CHRS | Common Stock, $0.0001 par value | I | 17,1700 | −48 329 | −830 | 286 076 | ||||
2021-09-29 | 2021-09-27 | 4 | HEALY JAMES | CHRS | Common Stock, $0.0001 par value | I | 18,0600 | −100 150 | −1 809 | 334 405 | ||||
2021-07-08 | 2021-07-06 | 4 | Anicetti Vincent R | CHRS | Stock Option (Right to Buy) | D | 13,63 | 150 000 | 150 000 | |||||
2021-07-08 | 2021-07-06 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 50 000 | 124 790 | ||||||
2021-06-10 | 2021-06-09 | 4 | Stilwell McDavid | CHRS | Common Stock | D | 13,4237 | 3 700 | 50 | 35 118 | ||||
2021-06-08 | 2021-06-08 | 4 | Lanfear Dennis M | CHRS | Stock Option (Right to Buy) | D | 0,42 | −31 054 | 0 | |||||
2021-06-08 | 2021-06-08 | 4 | Lanfear Dennis M | CHRS | Common Stock | D | 13,5644 | −31 054 | −421 | 493 258 | ||||
2021-06-08 | 2021-06-08 | 4 | Lanfear Dennis M | CHRS | Common Stock | D | 0,4168 | 31 054 | 13 | 524 312 | ||||
2021-06-08 | 2021-06-06 | 4 | Lanfear Dennis M | CHRS | Stock Option (Right to Buy) | D | 0,42 | −300 000 | 31 054 | |||||
2021-06-08 | 2021-06-06 | 4 | Lanfear Dennis M | CHRS | Common Stock | D | 0,4168 | 300 000 | 125 | 493 258 | ||||
2021-05-25 | 2021-05-21 | 4 | STOLPER MARK | CHRS | Stock Option (Right to Buy) | D | 13,48 | 20 000 | 20 000 | |||||
2021-05-25 | 2021-05-21 | 4 | MENDELSON ALAN C | CHRS | Stock Option (Right to Buy) | D | 13,48 | 20 000 | 20 000 | |||||
2021-04-30 | 2021-04-28 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 20 000 | 73 402 | ||||||
2021-04-30 | 2021-04-28 | 4 | Vexler Vladimir | CHRS | Common Stock | D | 20 000 | 73 386 | ||||||
2021-04-30 | 2021-04-28 | 4 | Stilwell McDavid | CHRS | Stock Option (Right to Buy) | D | 14,76 | 50 000 | 50 000 | |||||
2021-04-30 | 2021-04-28 | 4 | Stilwell McDavid | CHRS | Common Stock | D | 20 000 | 30 000 | ||||||
2021-03-16 | 3 | Stilwell McDavid | CHRS | Common Stock | D | 10 000 | ||||||||
2021-03-11 | 2021-03-09 | 4 | Vexler Vladimir | CHRS | Stock Option (Right to Buy) | D | 10,05 | −57 812 | 17 188 | |||||
2021-03-11 | 2021-03-09 | 4 | Vexler Vladimir | CHRS | Stock Option (Right to Buy) | D | 9,30 | −20 312 | 4 688 | |||||
2021-03-11 | 2021-03-09 | 4 | Vexler Vladimir | CHRS | Stock Option (Right to Buy) | D | 2,08 | −24 356 | 0 | |||||
2021-03-11 | 2021-03-09 | 4 | Vexler Vladimir | CHRS | Common Stock | D | 16,2488 | −114 240 | −1 856 | 53 386 | ||||
2021-03-11 | 2021-03-09 | 4 | Vexler Vladimir | CHRS | Common Stock | D | 10,0500 | 57 812 | 581 | 167 626 | ||||
2021-03-11 | 2021-03-09 | 4 | Vexler Vladimir | CHRS | Common Stock | D | 9,3000 | 20 312 | 189 | 109 814 | ||||
2021-03-11 | 2021-03-09 | 4 | Vexler Vladimir | CHRS | Common Stock | D | 2,0838 | 24 356 | 51 | 89 502 | ||||
2021-03-09 | 2021-03-05 | 4 | Anicetti Vincent R | CHRS | Stock Option (Right to Buy) | D | 9,30 | −20 312 | 4 688 | |||||
2021-03-09 | 2021-03-05 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 15,4600 | −6 337 | −98 | 53 402 | ||||
2021-03-09 | 2021-03-05 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 15,4635 | −20 312 | −314 | 59 739 | ||||
2021-03-09 | 2021-03-05 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 9,3000 | 20 312 | 189 | 80 051 | ||||
2021-02-19 | 2021-02-17 | 4 | Anicetti Vincent R | CHRS | Stock Option (Right to Buy) | D | 2,50 | −2 488 | 0 | |||||
2021-02-19 | 2021-02-17 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 17,4511 | −2 488 | −43 | 59 739 | ||||
2021-02-19 | 2021-02-17 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 2,5005 | 2 488 | 6 | 62 227 | ||||
2021-02-03 | 2021-02-01 | 4 | Lanfear Dennis M | CHRS | Stock Option (Right to Buy) | D | 17,60 | 125 000 | 125 000 | |||||
2021-02-03 | 2021-02-01 | 4 | Vexler Vladimir | CHRS | Stock Option (Right to Buy) | D | 17,60 | 50 000 | 50 000 | |||||
2021-02-03 | 2021-02-01 | 4 | Viret Jean-Frederic | CHRS | Stock Option (Right to Buy) | D | 10,05 | −7 402 | 54 167 | |||||
2021-02-03 | 2021-02-01 | 4 | Viret Jean-Frederic | CHRS | Common Stock | D | 21,5500 | −7 402 | −160 | 61 295 | ||||
2021-02-03 | 2021-02-01 | 4 | Viret Jean-Frederic | CHRS | Common Stock | D | 10,0500 | 7 402 | 74 | 68 697 | ||||
2021-01-27 | 2021-01-25 | 4 | Viret Jean-Frederic | CHRS | Stock Option (Right to Buy) | D | 10,05 | −40 000 | 61 569 | |||||
2021-01-27 | 2021-01-25 | 4 | Viret Jean-Frederic | CHRS | Common Stock | D | 19,0000 | −6 144 | −117 | 61 295 | ||||
2021-01-27 | 2021-01-25 | 4 | Viret Jean-Frederic | CHRS | Common Stock | D | 20,1000 | −40 000 | −804 | 67 439 | ||||
2021-01-27 | 2021-01-25 | 4 | Viret Jean-Frederic | CHRS | Common Stock | D | 10,0500 | 40 000 | 402 | 107 439 | ||||
2021-01-26 | 2021-01-23 | 4 | Lanfear Dennis M | CHRS | Stock Option (Right to Buy) | D | 18,33 | 500 000 | 500 000 | |||||
2021-01-21 | 2021-01-19 | 4 | Anicetti Vincent R | CHRS | Stock Option (Right to Buy) | D | 2,50 | −2 500 | 2 488 | |||||
2021-01-21 | 2021-01-19 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 17,9408 | −2 500 | −45 | 59 739 | ||||
2021-01-21 | 2021-01-19 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 2,5005 | 2 500 | 6 | 62 239 | ||||
2021-01-13 | 2021-01-11 | 4 | HEALY JAMES | CHRS | Stock Option (Right to Buy) | D | 17,58 | 20 000 | 20 000 | |||||
2021-01-13 | 2021-01-11 | 4 | Wahlstrom Mats | CHRS | Stock Option (Right to Buy) | D | 17,58 | 20 000 | 20 000 | |||||
2021-01-13 | 2021-01-11 | 4 | Szela Mary T | CHRS | Stock Option (Right to Buy) | D | 17,58 | 20 000 | 20 000 | |||||
2021-01-13 | 2021-01-11 | 4 | TZOUMAKAS KIMBERLY JO | CHRS | Stock Option (Right to Buy) | D | 17,58 | 20 000 | 20 000 | |||||
2021-01-13 | 2021-01-11 | 4 | LAWLIS V BRYAN | CHRS | Stock Option (Right to Buy) | D | 17,58 | 20 000 | 20 000 | |||||
2021-01-13 | 2021-01-11 | 4 | NUSSBAUM SAMUEL R MD | CHRS | Stock Option (Right to Buy) | D | 17,58 | 20 000 | 20 000 | |||||
2021-01-13 | 2021-01-11 | 4 | Vexler Vladimir | CHRS | Stock Option (Right to Buy) | D | 17,58 | 62 500 | 62 500 | |||||
2021-01-13 | 2021-01-11 | 4 | Vexler Vladimir | CHRS | Common Stock | D | 31 250 | 65 146 | ||||||
2021-01-13 | 2021-01-11 | 4 | Viret Jean-Frederic | CHRS | Stock Option (Right to Buy) | D | 17,58 | 62 500 | 62 500 | |||||
2021-01-13 | 2021-01-11 | 4 | Viret Jean-Frederic | CHRS | Common Stock | D | 31 250 | 67 439 | ||||||
2021-01-13 | 2021-01-11 | 4 | Anicetti Vincent R | CHRS | Stock Option (Right to Buy) | D | 17,58 | 62 500 | 62 500 | |||||
2021-01-13 | 2021-01-11 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 31 250 | 59 739 | ||||||
2021-01-12 | 2021-01-10 | 4 | Vexler Vladimir | CHRS | Common Stock | D | 18,1800 | −4 080 | −74 | 33 896 | ||||
2021-01-12 | 2021-01-10 | 4 | Viret Jean-Frederic | CHRS | Common Stock | D | 18,1800 | −4 080 | −74 | 36 189 | ||||
2021-01-12 | 2021-01-10 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 18,1800 | −4 080 | −74 | 28 489 | ||||
2021-01-07 | 2021-01-05 | 4 | MENDELSON ALAN C | CHRS | Stock Option (Right to Buy) | D | 16,85 | 40 000 | 40 000 | |||||
2021-01-07 | 3 | STOLPER MARK | CHRS | Common Stock | I | 8 800 | ||||||||
2021-01-07 | 2021-01-05 | 4 | STOLPER MARK | CHRS | Stock Option (Right to Buy) | D | 16,85 | 40 000 | 40 000 | |||||
2021-01-07 | 3 | MENDELSON ALAN C | CHRS | Common Stock | D | 1 000 | ||||||||
2021-01-07 | 3 | MENDELSON ALAN C | CHRS | Common Stock | I | 2 569 | ||||||||
2020-12-21 | 2020-12-17 | 4 | Anicetti Vincent R | CHRS | Stock Option (Right to Buy) | D | 2,50 | −2 500 | 4 988 | |||||
2020-12-21 | 2020-12-17 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 17,5120 | −2 500 | −44 | 32 569 | ||||
2020-12-21 | 2020-12-17 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 2,5005 | 2 500 | 6 | 35 069 | ||||
2020-12-11 | 2020-12-10 | 4 | Vexler Vladimir | CHRS | Stock Option (Right to Buy) | D | 2,08 | −17 626 | 24 356 | |||||
2020-12-11 | 2020-12-10 | 4 | Vexler Vladimir | CHRS | Common Stock | D | 18,0453 | −17 626 | −318 | 36 673 | ||||
2020-12-11 | 2020-12-10 | 4 | Vexler Vladimir | CHRS | Common Stock | D | 2,0838 | 17 626 | 37 | 54 299 | ||||
2020-12-11 | 2020-12-09 | 4 | Vexler Vladimir | CHRS | Stock Option (Right to Buy) | D | 2,08 | −30 000 | 41 982 | |||||
2020-12-11 | 2020-12-09 | 4 | Vexler Vladimir | CHRS | Common Stock | D | 18,2397 | −49 512 | −903 | 36 673 | ||||
2020-12-11 | 2020-12-09 | 4 | Vexler Vladimir | CHRS | Common Stock | D | 2,0838 | 30 000 | 63 | 86 185 | ||||
2020-12-09 | 2020-12-07 | 4 | Anicetti Vincent R | CHRS | Stock Option (Right to Buy) | D | 12,70 | −5 791 | 0 | |||||
2020-12-09 | 2020-12-07 | 4 | Anicetti Vincent R | CHRS | Stock Option (Right to Buy) | D | 12,37 | −3 000 | 123 000 | |||||
2020-12-09 | 2020-12-07 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 18,4161 | −8 791 | −162 | 32 569 | ||||
2020-12-09 | 2020-12-07 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 12,7000 | 5 791 | 74 | 41 360 | ||||
2020-12-09 | 2020-12-07 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 12,3700 | 3 000 | 37 | 35 569 | ||||
2020-12-07 | 2020-12-04 | 4 | Anicetti Vincent R | CHRS | Stock Option (Right to Buy) | D | 12,70 | −16 709 | 5 791 | |||||
2020-12-07 | 2020-12-04 | 4 | Anicetti Vincent R | CHRS | Stock Option (Right to Buy) | D | 16,75 | −32 291 | 17 709 | |||||
2020-12-07 | 2020-12-04 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 18,8509 | −49 000 | −924 | 32 569 | ||||
2020-12-07 | 2020-12-04 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 12,7000 | 16 709 | 212 | 81 569 | ||||
2020-12-07 | 2020-12-04 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 16,7500 | 32 291 | 541 | 64 860 | ||||
2020-12-07 | 2020-12-03 | 4 | Anicetti Vincent R | CHRS | Stock Option (Right to Buy) | D | 17,73 | −13 020 | 49 480 | |||||
2020-12-07 | 2020-12-03 | 4 | Anicetti Vincent R | CHRS | Stock Option (Right to Buy) | D | 17,17 | −36 736 | 0 | |||||
2020-12-07 | 2020-12-03 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 18,6727 | −49 756 | −929 | 32 569 | ||||
2020-12-07 | 2020-12-03 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 17,7300 | 13 020 | 231 | 82 325 | ||||
2020-12-07 | 2020-12-03 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 17,1700 | 36 736 | 631 | 69 305 | ||||
2020-11-19 | 2020-11-17 | 4 | Viret Jean-Frederic | CHRS | Stock Option (Right to Buy) | D | 13,50 | −1 500 | 110 241 | |||||
2020-11-19 | 2020-11-17 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 13,5000 | 1 500 | 20 | 40 269 | ||||
2020-11-19 | 2020-11-17 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 17,4919 | −1 995 | −35 | 38 769 | ||||
2020-11-19 | 2020-11-18 | 4 | Anicetti Vincent R | CHRS | Stock Option (Right to Buy) | D | 12,70 | −4 283 | 22 500 | |||||
2020-11-19 | 2020-11-18 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 18,0000 | −4 283 | −77 | 32 569 | ||||
2020-11-19 | 2020-11-18 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 12,7000 | 4 283 | 54 | 36 852 | ||||
2020-11-19 | 2020-11-17 | 4 | Anicetti Vincent R | CHRS | Stock Option (Right to Buy) | D | 2,50 | −2 500 | 7 488 | |||||
2020-11-19 | 2020-11-17 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 17,6770 | −3 567 | −63 | 32 569 | ||||
2020-11-19 | 2020-11-17 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 17,6827 | −12 420 | −220 | 36 136 | ||||
2020-11-19 | 2020-11-17 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 17,4974 | −2 500 | −44 | 48 556 | ||||
2020-11-19 | 2020-11-17 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 2,5005 | 2 500 | 6 | 51 056 | ||||
2020-10-21 | 2020-10-19 | 4 | Anicetti Vincent R | CHRS | Stock Option (Right to Buy) | D | 12,70 | −717 | 26 783 | |||||
2020-10-21 | 2020-10-19 | 4 | Anicetti Vincent R | CHRS | Stock Option (Right to Buy) | D | 2,50 | −2 500 | 9 988 | |||||
2020-10-21 | 2020-10-19 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 17,8911 | −3 217 | −58 | 48 556 | ||||
2020-10-21 | 2020-10-19 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 12,7000 | 717 | 9 | 51 773 | ||||
2020-10-21 | 2020-10-19 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 2,5005 | 2 500 | 6 | 51 056 | ||||
2020-10-16 | 2020-10-14 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 19,0000 | −6 144 | −117 | 40 423 | ||||
2020-10-01 | 2020-09-29 | 4 | HEALY JAMES | CHRS | Common Stock, $0.0001 par value | I | 213 546 | 434 555 | ||||||
2020-10-01 | 2020-09-29 | 4 | HEALY JAMES | CHRS | Common Stock, $0.0001 par value | I | −950 000 | 0 | ||||||
2020-09-21 | 2020-09-17 | 4 | Anicetti Vincent R | CHRS | Stock Option (Right to Buy) | D | 12,70 | −2 500 | 27 500 | |||||
2020-09-21 | 2020-09-17 | 4 | Anicetti Vincent R | CHRS | Stock Option (Right to Buy) | D | 2,50 | −2 500 | 27 500 | |||||
2020-09-21 | 2020-09-17 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 18,8432 | −5 000 | −94 | 48 556 | ||||
2020-09-21 | 2020-09-17 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 12,7000 | 2 500 | 32 | 53 556 | ||||
2020-09-21 | 2020-09-17 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 2,5005 | 2 500 | 6 | 51 056 | ||||
2020-09-01 | 2020-08-28 | 4 | HEALY JAMES | CHRS | Common Stock, $0.0001 par value | I | 221 009 | 221 009 | ||||||
2020-09-01 | 2020-08-28 | 4 | HEALY JAMES | CHRS | Common Stock, $0.0001 par value | I | −983 221 | 950 000 | ||||||
2020-08-19 | 2020-08-17 | 4 | Anicetti Vincent R | CHRS | Stock Option (Right to Buy) | D | 2,50 | −2 500 | 30 000 | |||||
2020-08-19 | 2020-08-17 | 4 | Anicetti Vincent R | CHRS | Stock Option (Right to Buy) | D | 12,70 | −2 500 | 30 000 | |||||
2020-08-19 | 2020-08-17 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 19,3702 | −5 000 | −97 | 48 556 | ||||
2020-08-19 | 2020-08-17 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 12,7000 | 2 500 | 32 | 53 556 | ||||
2020-08-19 | 2020-08-17 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 2,5005 | 2 500 | 6 | 51 056 | ||||
2020-08-03 | 2020-07-30 | 4 | TZOUMAKAS KIMBERLY JO | CHRS | Stock Option (Right to Buy) | D | 18,15 | 40 000 | 40 000 | |||||
2020-07-21 | 2020-07-17 | 4 | Anicetti Vincent R | CHRS | Stock Option (Right to Buy) | D | 12,70 | −12 500 | 32 500 | |||||
2020-07-21 | 2020-07-17 | 4 | Anicetti Vincent R | CHRS | Stock Option (Right to Buy) | D | 2,50 | −2 500 | 17 488 | |||||
2020-07-21 | 2020-07-17 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 18,2458 | −15 000 | −274 | 48 556 | ||||
2020-07-21 | 2020-07-17 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 12,7000 | 12 500 | 159 | 63 556 | ||||
2020-07-21 | 2020-07-17 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 2,5005 | 2 500 | 6 | 51 056 | ||||
2020-07-06 | 2020-07-01 | 4 | Lanfear Dennis M | CHRS | Stock Option (Right to Buy) | D | 0,01 | −29 994 | 0 | |||||
2020-07-06 | 2020-07-01 | 4 | Lanfear Dennis M | CHRS | Common Stock, $0.0001 par value | D | 0,0083 | 29 994 | 0 | 193 258 | ||||
2020-06-24 | 2020-06-22 | 4 | Szela Mary T | CHRS | Stock Option (Right to Buy) | D | 12,37 | −20 000 | 0 | |||||
2020-06-24 | 2020-06-22 | 4 | Szela Mary T | CHRS | Stock Option (Right to Buy) | D | 10,05 | −20 000 | 0 | |||||
2020-06-24 | 2020-06-22 | 4 | Szela Mary T | CHRS | Stock Option (Right to Buy) | D | 2,50 | −14 997 | 0 | |||||
2020-06-24 | 2020-06-22 | 4 | Szela Mary T | CHRS | Common Stock, $0.0001 par value | D | 17,5784 | −54 997 | −967 | 0 | ||||
2020-06-24 | 2020-06-22 | 4 | Szela Mary T | CHRS | Common Stock, $0.0001 par value | D | 12,3700 | 20 000 | 247 | 54 997 | ||||
2020-06-24 | 2020-06-22 | 4 | Szela Mary T | CHRS | Common Stock, $0.0001 par value | D | 10,0500 | 20 000 | 201 | 34 997 | ||||
2020-06-24 | 2020-06-22 | 4 | Szela Mary T | CHRS | Common Stock, $0.0001 par value | D | 2,5005 | 14 997 | 37 | 14 997 | ||||
2020-06-19 | 2020-06-17 | 4 | Wahlstrom Mats | CHRS | Common Stock, $0.0001 par value | I | 17,1501 | −200 000 | −3 430 | 0 | ||||
2020-06-19 | 2020-06-17 | 4 | Anicetti Vincent R | CHRS | Stock Option (Right to Buy) | D | 2,50 | −2 500 | 19 988 | |||||
2020-06-19 | 2020-06-17 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 17,2200 | −2 500 | −43 | 48 556 | ||||
2020-06-19 | 2020-06-17 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 2,5005 | 2 500 | 6 | 51 056 | ||||
2020-05-22 | 2020-05-20 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 17,6600 | −1 278 | −23 | 46 567 | ||||
2020-05-20 | 2020-05-18 | 4 | Anicetti Vincent R | CHRS | Stock Option (Right to Buy) | D | 2,50 | −2 500 | 22 488 | |||||
2020-05-20 | 2020-05-18 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 17,1700 | −2 500 | −43 | 48 556 | ||||
2020-05-20 | 2020-05-18 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 2,5005 | 2 500 | 6 | 51 056 | ||||
2020-05-20 | 2020-05-18 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 17,1700 | −593 | −10 | 48 556 | ||||
2020-04-21 | 2020-04-20 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 17,0000 | −5 150 | −88 | 47 846 | ||||
2020-04-21 | 2020-04-17 | 4 | Anicetti Vincent R | CHRS | Stock Option (Right to Buy) | D | 2,50 | −5 000 | 24 988 | |||||
2020-04-21 | 2020-04-17 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 15,5700 | −5 000 | −78 | 52 996 | ||||
2020-04-21 | 2020-04-17 | 4 | Anicetti Vincent R | CHRS | Common Stock | D | 2,5005 | 5 000 | 13 | 57 996 | ||||
2020-03-05 | 2020-03-03 | 4 | Wahlstrom Mats | CHRS | Common Stock, $0.0001 par value | I | 20,8941 | −4 222 | −88 | 200 000 | ||||
2020-03-05 | 2020-03-03 | 4 | Wahlstrom Mats | CHRS | Common Stock, $0.0001 par value | I | 20,0906 | −113 844 | −2 287 | 204 222 | ||||
2020-02-21 | 2020-02-19 | 4 | Viret Jean-Frederic | CHRS | Stock Option (Right to Buy) | D | 10,05 | −3 159 | 101 569 | |||||
2020-02-21 | 2020-02-19 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 22,3336 | −3 159 | −71 | 46 841 | ||||
2020-02-21 | 2020-02-19 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 10,0500 | 3 159 | 32 | 50 000 | ||||
2020-02-20 | 2020-02-18 | 4 | Anicetti Vincent R | CHRS | Stock Option (Right to Buy) | D | 2,50 | −2 500 | 45 000 | |||||
2020-02-20 | 2020-02-18 | 4 | Anicetti Vincent R | CHRS | Stock Option (Right to Buy) | D | 12,70 | −2 500 | 45 000 | |||||
2020-02-20 | 2020-02-18 | 4 | Anicetti Vincent R | CHRS | Common Stock, $0.0001 par value | D | 21,6380 | −5 000 | −108 | 52 996 | ||||
2020-02-20 | 2020-02-18 | 4 | Anicetti Vincent R | CHRS | Common Stock, $0.0001 par value | D | 21,6400 | −2 500 | −54 | 57 996 | ||||
2020-02-20 | 2020-02-18 | 4 | Anicetti Vincent R | CHRS | Common Stock, $0.0001 par value | D | 21,6400 | −2 500 | −54 | 57 996 | ||||
2020-02-20 | 2020-02-18 | 4 | Anicetti Vincent R | CHRS | Common Stock, $0.0001 par value | D | 12,7000 | 2 500 | 32 | 60 496 | ||||
2020-02-20 | 2020-02-18 | 4 | Anicetti Vincent R | CHRS | Common Stock, $0.0001 par value | D | 2,5005 | 2 500 | 6 | 60 496 | ||||
2020-01-22 | 2020-01-17 | 4 | Anicetti Vincent R | CHRS | Stock Option (Right to Buy) | D | 12,70 | −2 500 | 47 500 | |||||
2020-01-22 | 2020-01-17 | 4 | Anicetti Vincent R | CHRS | Stock Option (Right to Buy) | D | 2,50 | −2 500 | 47 500 | |||||
2020-01-22 | 2020-01-17 | 4 | Anicetti Vincent R | CHRS | Common Stock, $0.0001 par value | D | 19,6853 | −2 500 | −49 | 57 996 | ||||
2020-01-22 | 2020-01-17 | 4 | Anicetti Vincent R | CHRS | Common Stock, $0.0001 par value | D | 12,7000 | 2 500 | 32 | 60 496 | ||||
2020-01-22 | 2020-01-17 | 4 | Anicetti Vincent R | CHRS | Common Stock, $0.0001 par value | D | 19,5592 | −5 000 | −98 | 57 996 | ||||
2020-01-22 | 2020-01-17 | 4 | Anicetti Vincent R | CHRS | Common Stock, $0.0001 par value | D | 19,5685 | −2 500 | −49 | 62 996 | ||||
2020-01-22 | 2020-01-17 | 4 | Anicetti Vincent R | CHRS | Common Stock, $0.0001 par value | D | 2,5005 | 2 500 | 6 | 65 496 | ||||
2020-01-17 | 2020-01-15 | 4 | Viret Jean-Frederic | CHRS | Stock Option (Right to Buy) | D | 10,05 | −6 318 | 104 728 | |||||
2020-01-17 | 2020-01-15 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 20,0807 | −2 798 | −56 | 46 841 | ||||
2020-01-17 | 2020-01-15 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 19,6699 | −3 520 | −69 | 49 639 | ||||
2020-01-17 | 2020-01-15 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 10,0500 | 6 318 | 63 | 53 159 | ||||
2020-01-14 | 2020-01-10 | 4 | Szela Mary T | CHRS | Stock Option (Right to Buy) | D | 17,73 | 20 000 | 20 000 | |||||
2020-01-14 | 2020-01-10 | 4 | Satvat Ali J. | CHRS | Stock Option (Right to Buy) | D | 17,73 | 20 000 | 20 000 | |||||
2020-01-14 | 2020-01-10 | 4 | Anicetti Vincent R | CHRS | Stock Option (Right to Buy) | D | 17,73 | 62 500 | 62 500 | |||||
2020-01-14 | 2020-01-10 | 4 | Anicetti Vincent R | CHRS | Common Stock, $0.0001 par value | D | 31 250 | 62 996 | ||||||
2020-01-14 | 2020-01-10 | 4 | Anicetti Vincent R | CHRS | Common Stock, $0.0001 par value | D | 17,7300 | −7 146 | −127 | 31 746 | ||||
2020-01-14 | 2020-01-10 | 4 | Anicetti Vincent R | CHRS | Common Stock, $0.0001 par value | D | 19 566 | 38 892 | ||||||
2020-01-14 | 2020-01-10 | 4 | Viret Jean-Frederic | CHRS | Stock Option (Right to Buy) | D | 17,73 | 62 500 | 62 500 | |||||
2020-01-14 | 2020-01-10 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 31 250 | 46 841 | ||||||
2020-01-14 | 2020-01-10 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 17,7300 | −7 077 | −125 | 15 591 | ||||
2020-01-14 | 2020-01-10 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 19 365 | 22 668 | ||||||
2020-01-14 | 2020-01-10 | 4 | Vexler Vladimir | CHRS | Stock Option (Right to Buy) | D | 17,73 | 62 500 | 62 500 | |||||
2020-01-14 | 2020-01-10 | 4 | Vexler Vladimir | CHRS | Common Stock, $0.0001 par value | D | 31 250 | 56 185 | ||||||
2020-01-14 | 2020-01-10 | 4 | Vexler Vladimir | CHRS | Common Stock, $0.0001 par value | D | 17,7300 | −3 477 | −62 | 24 935 | ||||
2020-01-14 | 2020-01-10 | 4 | Vexler Vladimir | CHRS | Common Stock, $0.0001 par value | D | 8 900 | 28 412 | ||||||
2020-01-14 | 2020-01-10 | 4 | Lanfear Dennis M | CHRS | Stock Option (Right to Buy) | D | 17,73 | 500 000 | 500 000 | |||||
2020-01-14 | 2020-01-10 | 4 | Lanfear Dennis M | CHRS | Common Stock, $0.0001 par value | D | 17,7300 | −21 516 | −381 | 163 264 | ||||
2020-01-14 | 2020-01-10 | 4 | Lanfear Dennis M | CHRS | Common Stock, $0.0001 par value | D | 59 763 | 184 780 | ||||||
2020-01-14 | 2020-01-10 | 4 | NUSSBAUM SAMUEL R MD | CHRS | Stock Option (Right to Buy) | D | 17,73 | 20 000 | 20 000 | |||||
2020-01-14 | 2020-01-10 | 4 | Richards Christos | CHRS | Stock Option (Right to Buy) | D | 17,73 | 20 000 | 20 000 | |||||
2020-01-14 | 2020-01-10 | 4 | LAWLIS V BRYAN | CHRS | Stock Option (Right to Buy) | D | 17,73 | 20 000 | 20 000 | |||||
2020-01-14 | 2020-01-10 | 4 | HEALY JAMES | CHRS | Stock Option (Right to Buy) | D | 17,73 | 20 000 | 20 000 | |||||
2020-01-14 | 2020-01-10 | 4 | Wahlstrom Mats | CHRS | Stock Option (Right to Buy) | D | 17,73 | 20 000 | 20 000 | |||||
2020-01-13 | 2020-01-12 | 4 | HEALY JAMES | CHRS | Stock Option (Right to Buy) | D | 12,37 | −20 000 | 0 | |||||
2020-01-13 | 2020-01-12 | 4 | HEALY JAMES | CHRS | Common Stock, $0.0001 par value | D | 12,3700 | 20 000 | 247 | 70 086 | ||||
2020-01-13 | 2020-01-09 | 4 | HEALY JAMES | CHRS | Stock Option (Right to Buy) | D | 10,05 | −20 000 | 0 | |||||
2020-01-13 | 2020-01-09 | 4 | HEALY JAMES | CHRS | Stock Option (Right to Buy) | D | 1,67 | −29 994 | 0 | |||||
2020-01-13 | 2020-01-09 | 4 | HEALY JAMES | CHRS | Common Stock, $0.0001 par value | D | 10,0500 | 20 000 | 201 | 50 086 | ||||
2020-01-13 | 2020-01-09 | 4 | HEALY JAMES | CHRS | Common Stock, $0.0001 par value | D | 1,6670 | 29 994 | 50 | 30 086 | ||||
2020-01-08 | 3 | Temasek Holdings (Private) Ltd | CHRS | Common Stock | D | 14 762 232 | ||||||||
2020-01-08 | 3 | Temasek Holdings (Private) Ltd | CHRS | Common Stock | D | 14 762 232 | ||||||||
2020-01-08 | 3 | Temasek Holdings (Private) Ltd | CHRS | Common Stock | D | 14 762 232 | ||||||||
2020-01-08 | 3 | Temasek Holdings (Private) Ltd | CHRS | Common Stock | D | 14 762 232 | ||||||||
2020-01-08 | 3 | Temasek Holdings (Private) Ltd | CHRS | Common Stock | D | 14 762 232 | ||||||||
2020-01-08 | 3 | Temasek Holdings (Private) Ltd | CHRS | Common Stock | D | 14 762 232 | ||||||||
2019-12-18 | 2019-12-16 | 4 | Anicetti Vincent R | CHRS | Stock Option (Right to Buy) | D | 2,50 | −2 500 | 34 988 | |||||
2019-12-18 | 2019-12-16 | 4 | Anicetti Vincent R | CHRS | Common Stock, $0.0001 par value | D | 18,6900 | −2 500 | −47 | 19 326 | ||||
2019-12-18 | 2019-12-16 | 4 | Anicetti Vincent R | CHRS | Common Stock, $0.0001 par value | D | 2,5005 | 2 500 | 6 | 21 826 | ||||
2019-11-25 | 2019-11-21 | 4 | Lanfear Dennis M By Trust | CHRS | Common Stock, $0.0001 par value | I | 18,5568 | −12 500 | −232 | 446 684 | ||||
2019-11-22 | 2019-11-20 | 4 | Lanfear Dennis M By Trust | CHRS | Common Stock, $0.0001 par value | I | 18,0000 | −825 000 | −14 850 | 459 184 | ||||
2019-11-22 | 2019-11-20 | 4 | Viret Jean-Frederic | CHRS | Stock Option (Right to Buy) | D | 10,05 | −3 159 | 111 046 | |||||
2019-11-22 | 2019-11-20 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 19,5859 | −3 159 | −62 | 3 303 | ||||
2019-11-22 | 2019-11-20 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 10,0500 | 3 159 | 32 | 6 462 | ||||
2019-11-20 | 2019-11-18 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 18,8809 | −3 112 | −59 | 3 303 | ||||
2019-11-18 | 2019-11-14 | 4 | Anicetti Vincent R | CHRS | Stock Option (Right to Buy) | D | 2,50 | −2 500 | 37 488 | |||||
2019-11-18 | 2019-11-14 | 4 | Anicetti Vincent R | CHRS | Common Stock, $0.0001 par value | D | 19,2600 | −2 500 | −48 | 19 310 | ||||
2019-11-18 | 2019-11-14 | 4 | Anicetti Vincent R | CHRS | Common Stock, $0.0001 par value | D | 2,5005 | 2 500 | 6 | 21 810 | ||||
2019-10-22 | 2019-10-18 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 19,0200 | −1 388 | −26 | 6 385 | ||||
2019-10-18 | 2019-10-16 | 4 | Viret Jean-Frederic | CHRS | Stock Option (Right to Buy) | D | 10,05 | −3 159 | 114 205 | |||||
2019-10-18 | 2019-10-16 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 19,0000 | −3 159 | −60 | 7 773 | ||||
2019-10-18 | 2019-10-16 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 10,0500 | 3 159 | 32 | 10 932 | ||||
2019-10-16 | 2019-10-14 | 4 | Anicetti Vincent R | CHRS | Stock Option (Right to Buy) | D | 2,50 | −2 500 | 39 988 | |||||
2019-10-16 | 2019-10-14 | 4 | Anicetti Vincent R | CHRS | Common Stock, $0.0001 par value | D | 18,4000 | −2 500 | −46 | 19 310 | ||||
2019-10-16 | 2019-10-14 | 4 | Anicetti Vincent R | CHRS | Common Stock, $0.0001 par value | D | 2,5005 | 2 500 | 6 | 21 810 | ||||
2019-09-25 | 2019-09-23 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 21,7800 | −740 | −16 | 7 773 | ||||
2019-09-20 | 2019-09-18 | 4 | Viret Jean-Frederic | CHRS | Stock Option (Right to Buy) | D | 10,05 | −3 159 | 117 364 | |||||
2019-09-20 | 2019-09-18 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 20,4368 | −3 159 | −65 | 8 513 | ||||
2019-09-20 | 2019-09-18 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 10,0500 | 3 159 | 32 | 11 672 | ||||
2019-09-18 | 2019-09-16 | 4 | Anicetti Vincent R | CHRS | Stock Option (Right to Buy) | D | 2,50 | −2 500 | 42 488 | |||||
2019-09-18 | 2019-09-16 | 4 | Anicetti Vincent R | CHRS | Common Stock, $0.0001 par value | D | 20,0300 | −2 500 | −50 | 19 310 | ||||
2019-09-18 | 2019-09-16 | 4 | Anicetti Vincent R | CHRS | Common Stock, $0.0001 par value | D | 2,5005 | 2 500 | 6 | 21 810 | ||||
2019-08-23 | 2019-08-21 | 4 | Viret Jean-Frederic | CHRS | Stock Option (Right to Buy) | D | 10,05 | −6 318 | 120 523 | |||||
2019-08-23 | 2019-08-21 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 21,7507 | −6 058 | −132 | 8 513 | ||||
2019-08-23 | 2019-08-21 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 20,7257 | −260 | −5 | 14 571 | ||||
2019-08-23 | 2019-08-21 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 10,0500 | 6 318 | 63 | 14 831 | ||||
2019-08-21 | 2019-08-19 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 19,0400 | −3 000 | −57 | 8 513 | ||||
2019-08-16 | 2019-08-14 | 4 | Anicetti Vincent R | CHRS | Stock Option (Right to Buy) | D | 2,50 | −2 500 | 44 988 | |||||
2019-08-16 | 2019-08-14 | 4 | Anicetti Vincent R | CHRS | Common Stock, $0.0001 par value | D | 19,0000 | −2 500 | −48 | 19 310 | ||||
2019-08-16 | 2019-08-14 | 4 | Anicetti Vincent R | CHRS | Common Stock, $0.0001 par value | D | 2,5005 | 2 500 | 6 | 21 810 | ||||
2019-07-17 | 2019-07-15 | 4 | Anicetti Vincent R | CHRS | Stock Option (Right to Buy) | D | 2,50 | −2 500 | 47 488 | |||||
2019-07-17 | 2019-07-15 | 4 | Anicetti Vincent R | CHRS | Common Stock, $0.0001 par value | D | 19,2000 | −2 500 | −48 | 19 310 | ||||
2019-07-17 | 2019-07-15 | 4 | Anicetti Vincent R | CHRS | Common Stock, $0.0001 par value | D | 2,5005 | 2 500 | 6 | 21 810 | ||||
2019-07-02 | 2019-07-02 | 4 | HEALY JAMES | CHRS | Common Stock, $0.0001 par value | I | 22,6100 | −160 000 | −3 618 | 1 933 221 | ||||
2019-07-02 | 2019-06-28 | 4 | HEALY JAMES | CHRS | Common Stock, $0.0001 par value | I | 22,0500 | −200 000 | −4 410 | 2 093 221 | ||||
2019-06-24 | 2019-06-20 | 4 | HEALY JAMES | CHRS | Common Stock, $0.0001 par value | I | 21,3700 | −317 130 | −6 777 | 2 293 221 | ||||
2019-06-20 | 2019-06-19 | 4 | Viret Jean-Frederic | CHRS | Stock Option (Right to Buy) | D | 10,05 | −3 159 | 126 841 | |||||
2019-06-20 | 2019-06-19 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 20,8100 | −100 | −2 | 11 513 | ||||
2019-06-20 | 2019-06-19 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 20,3224 | −3 059 | −62 | 11 613 | ||||
2019-06-20 | 2019-06-19 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 10,0500 | 3 159 | 32 | 14 672 | ||||
2019-06-20 | 2019-06-19 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 20,0000 | −667 | −13 | 11 513 | ||||
2019-06-20 | 2019-06-18 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 19,3088 | −3 000 | −58 | 12 180 | ||||
2019-06-04 | 2019-05-31 | 4 | Wahlstrom Mats | CHRS | Common Stock, $0.0001 par value | I | 98 152 | 318 066 | ||||||
2019-06-04 | 2019-05-31 | 4 | Wahlstrom Mats | CHRS | Common Stock, $0.0001 par value | I | −178 528 | 0 | ||||||
2019-05-31 | 2019-05-30 | 4 | Lanfear Dennis M By Trust | CHRS | Common Stock, $0.0001 par value | I | 19,4852 | −32 398 | −631 | 1 284 184 | ||||
2019-05-24 | 2019-05-22 | 4 | HEALY JAMES | CHRS | Common Stock, $0.0001 par value | I | 20,6900 | −257 870 | −5 335 | 2 610 351 | ||||
2019-03-22 | 2019-03-20 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 14,9207 | −3 000 | −45 | 13 185 | ||||
2019-01-30 | 2019-01-11 | 4 | Satvat Ali J. | CHRS | Stock Option (Right to Buy) | D | 12,37 | 20 000 | 20 000 | |||||
2019-01-30 | 2019-01-11 | 4 | Richards Christos | CHRS | Stock Option (Right to Buy) | D | 12,37 | 20 000 | 20 000 | |||||
2019-01-30 | 2019-01-11 | 4 | Wahlstrom Mats | CHRS | Stock Option (Right to Buy) | D | 12,37 | 20 000 | 20 000 | |||||
2019-01-30 | 2019-01-11 | 4 | HEALY JAMES | CHRS | Stock Option (Right to Buy) | D | 12,37 | 20 000 | 20 000 | |||||
2019-01-30 | 2019-01-11 | 4 | NUSSBAUM SAMUEL R MD | CHRS | Stock Option (Right to Buy) | D | 12,37 | 20 000 | 20 000 | |||||
2019-01-30 | 2019-01-11 | 4 | Szela Mary T | CHRS | Stock Option (Right to Buy) | D | 12,37 | 20 000 | 20 000 | |||||
2019-01-30 | 2019-01-11 | 4 | LAWLIS V BRYAN | CHRS | Stock Option (Right to Buy) | D | 12,37 | 20 000 | 20 000 | |||||
2019-01-15 | 3/A | Vexler Vladimir | CHRS | Common Stock, $0.0001 par value | D | 7 828 | ||||||||
2019-01-15 | 2018-11-16 | 4/A | Vexler Vladimir | CHRS | Stock Option (Right to Buy) | D | 12,27 | 35 000 | 35 000 | |||||
2019-01-15 | 2019-01-11 | 4 | Anicetti Vincent R | CHRS | Stock Option (Right to Buy) | D | 12,37 | 126 000 | 126 000 | |||||
2019-01-15 | 2019-01-11 | 4 | Anicetti Vincent R | CHRS | Common Stock, $0.0001 par value | D | 12,3700 | −6 404 | −79 | 17 295 | ||||
2019-01-15 | 2019-01-11 | 4 | Anicetti Vincent R | CHRS | Common Stock, $0.0001 par value | D | 16 997 | 23 699 | ||||||
2019-01-15 | 2019-01-11 | 4 | Vexler Vladimir | CHRS | Stock Option (Right to Buy) | D | 12,37 | 126 000 | 126 000 | |||||
2019-01-15 | 2019-01-11 | 4 | Vexler Vladimir | CHRS | Common Stock, $0.0001 par value | D | 12,3700 | −5 916 | −73 | 17 474 | ||||
2019-01-15 | 2019-01-11 | 4 | Vexler Vladimir | CHRS | Common Stock, $0.0001 par value | D | 15 562 | 23 390 | ||||||
2019-01-15 | 2019-01-11 | 4 | Viret Jean-Frederic | CHRS | Stock Option (Right to Buy) | D | 12,37 | 126 000 | 126 000 | |||||
2019-01-15 | 2019-01-11 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 12,3700 | −6 297 | −78 | 16 185 | ||||
2019-01-15 | 2019-01-11 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 16 685 | 22 482 | ||||||
2019-01-15 | 2019-01-11 | 4 | Lanfear Dennis M | CHRS | Stock Option (Right to Buy) | D | 12,37 | 450 000 | 450 000 | |||||
2019-01-15 | 2019-01-11 | 4 | Lanfear Dennis M | CHRS | Common Stock, $0.0001 par value | D | 12,3700 | −17 867 | −221 | 125 017 | ||||
2019-01-15 | 2019-01-11 | 4 | Lanfear Dennis M | CHRS | Common Stock, $0.0001 par value | D | 50 265 | 142 884 | ||||||
2019-01-14 | 3/A | Vexler Vladimir | CHRS | Common Stock, $0.0001 par value | D | 10 800 | ||||||||
2019-01-14 | 2018-11-16 | 4/A | Vexler Vladimir | CHRS | Stock Option (Right to Buy) | D | 12,27 | 35 000 | 35 000 | |||||
2018-11-20 | 2018-11-16 | 4 | Vexler Vladimir | CHRS | Stock Option (Right to Buy) | D | 12,27 | 35 000 | 35 000 | |||||
2018-11-20 | 3 | Vexler Vladimir | CHRS | Common Stock, $0.0001 par value | D | 24 600 | ||||||||
2018-11-20 | 3 | Vexler Vladimir | CHRS | Common Stock, $0.0001 par value | D | 24 600 | ||||||||
2018-11-20 | 3 | Vexler Vladimir | CHRS | Common Stock, $0.0001 par value | D | 24 600 | ||||||||
2018-09-25 | 2018-09-21 | 4 | Viret Jean-Frederic | CHRS | Stock Option (Right to Buy) | D | 13,50 | −740 | 111 741 | |||||
2018-09-25 | 2018-09-21 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 13,5000 | 740 | 10 | 4 519 | ||||
2018-09-12 | 2018-09-10 | 4 | FINCK BARBARA K | CHRS | Stock Option (right to buy) | D | 1,42 | −1 760 | 82 941 | |||||
2018-09-12 | 2018-09-10 | 4 | FINCK BARBARA K | CHRS | Common Stock, $0.0001 par value | D | 18,5789 | −1 760 | −33 | 37 043 | ||||
2018-09-12 | 2018-09-10 | 4 | FINCK BARBARA K | CHRS | Common Stock, $0.0001 par value | D | 1,4200 | 1 760 | 2 | 38 803 | ||||
2018-08-31 | 2018-08-29 | 4 | HEALY JAMES | CHRS | Common Stock, $0.0001 par value | I | 20,5000 | −25 000 | −512 | 2 868 221 | ||||
2018-08-15 | 2018-08-13 | 4 | FINCK BARBARA K | CHRS | Stock Option (right to buy) | D | 1,42 | −1 760 | 84 701 | |||||
2018-08-15 | 2018-08-13 | 4 | FINCK BARBARA K | CHRS | Common Stock, $0.0001 par value | D | 19,0227 | −1 760 | −33 | 37 043 | ||||
2018-08-15 | 2018-08-13 | 4 | FINCK BARBARA K | CHRS | Common Stock, $0.0001 par value | D | 1,4200 | 1 760 | 2 | 38 803 | ||||
2018-07-25 | 2018-07-23 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 18,5633 | −9 291 | −172 | 3 779 | ||||
2018-07-11 | 2018-07-10 | 4 | FINCK BARBARA K | CHRS | Stock Option (right to buy) | D | 1,42 | −1 260 | 86 461 | |||||
2018-07-11 | 2018-07-10 | 4 | FINCK BARBARA K | CHRS | Common Stock, $0.0001 par value | D | 15,0000 | −1 260 | −19 | 37 043 | ||||
2018-07-11 | 2018-07-10 | 4 | FINCK BARBARA K | CHRS | Common Stock, $0.0001 par value | D | 1,4200 | 1 260 | 2 | 38 303 | ||||
2018-07-11 | 2018-07-09 | 4 | FINCK BARBARA K | CHRS | Stock Option (right to buy) | D | 1,42 | −500 | 87 721 | |||||
2018-07-11 | 2018-07-09 | 4 | FINCK BARBARA K | CHRS | Common Stock, $0.0001 par value | D | 15,0300 | −500 | −8 | 37 043 | ||||
2018-07-11 | 2018-07-09 | 4 | FINCK BARBARA K | CHRS | Common Stock, $0.0001 par value | D | 1,4200 | 500 | 1 | 37 543 | ||||
2018-06-20 | 2018-06-18 | 4 | FINCK BARBARA K | CHRS | Stock Option (right to buy) | D | 1,42 | −1 760 | 88 221 | |||||
2018-06-20 | 2018-06-18 | 4 | FINCK BARBARA K | CHRS | Common Stock, $0.0001 par value | D | 15,0000 | −1 760 | −26 | 37 043 | ||||
2018-06-20 | 2018-06-18 | 4 | FINCK BARBARA K | CHRS | Common Stock, $0.0001 par value | D | 1,4200 | 1 760 | 2 | 38 803 | ||||
2018-05-17 | 2018-05-16 | 4 | Lanfear Dennis M By Trust | CHRS | Common Stock, $0.0001 par value | I | 16,2631 | −20 984 | −341 | 1 316 582 | ||||
2018-05-16 | 2018-05-14 | 4 | Anicetti Vincent R | CHRS | Stock Option (Right to Buy) | D | 16,75 | 50 000 | 50 000 | |||||
2018-05-11 | 2018-05-09 | 4 | NUSSBAUM SAMUEL R MD | CHRS | Stock Option (Right to Buy) | D | 15,60 | 40 000 | 40 000 | |||||
2018-03-05 | 3 | Anicetti Vincent R | CHRS | Common Stock, $0.0001 par value | D | 10 300 | ||||||||
2018-03-05 | 3 | Anicetti Vincent R | CHRS | Common Stock, $0.0001 par value | D | 10 300 | ||||||||
2018-03-05 | 2018-03-01 | 4 | Anicetti Vincent R | CHRS | Stock Option (Right to Buy) | D | 9,80 | 25 000 | 25 000 | |||||
2018-02-05 | 2018-02-01 | 4 | Richards Christos | CHRS | Stock Option (Right to Buy) | D | 10,05 | 20 000 | 20 000 | |||||
2018-02-05 | 2018-02-01 | 4 | Wahlstrom Mats | CHRS | Stock Option (Right to Buy) | D | 10,05 | 20 000 | 20 000 | |||||
2018-02-05 | 2018-02-01 | 4 | Lanfear Dennis M | CHRS | Stock Option (Right to Buy) | D | 10,05 | 400 000 | 400 000 | |||||
2018-02-05 | 2018-02-01 | 4 | Viret Jean-Frederic | CHRS | Stock Option (Right to Buy) | D | 10,05 | 130 000 | 130 000 | |||||
2018-02-05 | 2018-02-01 | 4 | FINCK BARBARA K | CHRS | Stock Option (Right to Buy) | D | 10,05 | 130 000 | 130 000 | |||||
2018-02-05 | 2018-02-01 | 4 | Satvat Ali J. | CHRS | Stock Option (Right to Buy) | D | 10,05 | 20 000 | 20 000 | |||||
2018-02-05 | 2018-02-01 | 4 | Troendle August J. | CHRS | Stock Option (Right to Buy) | D | 10,05 | 20 000 | 20 000 | |||||
2018-02-05 | 2018-02-01 | 4 | Szela Mary T | CHRS | Stock Option (Right to Buy) | D | 10,05 | 20 000 | 20 000 | |||||
2018-02-05 | 2018-02-01 | 4 | Watler Peter K. | CHRS | Stock Option (Right to Buy) | D | 10,05 | 50 000 | 50 000 | |||||
2018-02-05 | 2018-02-01 | 4 | LAWLIS V BRYAN | CHRS | Stock Option (Right to Buy) | D | 10,05 | 20 000 | 20 000 | |||||
2018-02-05 | 2018-02-01 | 4 | HEALY JAMES | CHRS | Stock Option (Right to Buy) | D | 10,05 | 20 000 | 20 000 | |||||
2017-12-19 | 2017-12-15 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 6 966 | 9 958 | ||||||
2017-12-19 | 2017-12-15 | 4 | Lanfear Dennis M | CHRS | Common Stock, $0.0001 par value | D | 20 984 | 92 619 | ||||||
2017-12-19 | 2017-12-15 | 4 | Watler Peter K. | CHRS | Common Stock, $0.0001 par value | D | 5 900 | 5 900 | ||||||
2017-12-19 | 2017-12-15 | 4 | FINCK BARBARA K | CHRS | Common Stock, $0.0001 par value | D | 7 545 | 34 336 | ||||||
2017-12-19 | 2017-12-15 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 809 | 50 460 | ||||||
2017-08-31 | 3 | V-Sciences Investments Pte Ltd | CHRS | Common Stock | D | 13 112 232 | ||||||||
2017-08-31 | 3 | V-Sciences Investments Pte Ltd | CHRS | Common Stock | D | 13 112 232 | ||||||||
2017-08-31 | 3 | V-Sciences Investments Pte Ltd | CHRS | Common Stock | D | 13 112 232 | ||||||||
2017-08-31 | 3 | V-Sciences Investments Pte Ltd | CHRS | Common Stock | D | 13 112 232 | ||||||||
2017-08-31 | 3 | V-Sciences Investments Pte Ltd | CHRS | Common Stock | D | 13 112 232 | ||||||||
2017-08-10 | 2017-08-08 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 15,0157 | −17 535 | −263 | 49 651 | ||||
2017-08-08 | 2017-08-06 | 4 | Lanfear Dennis M | CHRS | Stock Option (Right to Buy) | D | 12,70 | 200 000 | 200 000 | |||||
2017-08-08 | 2017-08-06 | 4 | FINCK BARBARA K | CHRS | Stock Option (Right to Buy) | D | 12,70 | 67 000 | 67 000 | |||||
2017-08-08 | 2017-08-06 | 4 | Viret Jean-Frederic | CHRS | Stock Option (Right to Buy) | D | 12,70 | 67 000 | 67 000 | |||||
2017-08-08 | 2017-08-06 | 4 | Watler Peter K. | CHRS | Stock Option (Right to Buy) | D | 12,70 | 67 000 | 67 000 | |||||
2017-07-07 | 2017-07-05 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 15,0000 | −600 | −9 | 67 186 | ||||
2017-06-05 | 2017-06-01 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 20,9827 | −1 732 | −36 | 67 786 | ||||
2017-06-05 | 2017-06-01 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 20,2010 | −9 601 | −194 | 69 518 | ||||
2017-05-19 | 2017-05-17 | 4 | Wahlstrom Mats | CHRS | Stock Option (Right to Buy) | D | 23,80 | 20 000 | 20 000 | |||||
2017-05-19 | 2017-05-09 | 4 | Wahlstrom Mats | CHRS | Common Stock, $0.0001 par value | I | 109 957 | 219 914 | ||||||
2017-05-19 | 2017-05-09 | 4 | Wahlstrom Mats | CHRS | Common Stock, $0.0001 par value | I | −200 000 | 178 528 | ||||||
2017-05-19 | 2017-02-22 | 4 | Wahlstrom Mats | CHRS | Common Stock, $0.0001 par value | I | 109 957 | 109 957 | ||||||
2017-05-19 | 2017-02-22 | 4 | Wahlstrom Mats | CHRS | Common Stock, $0.0001 par value | I | −200 000 | 378 528 | ||||||
2017-05-19 | 2017-05-17 | 4 | Richards Christos | CHRS | Stock Option (Right to Buy) | D | 23,80 | 20 000 | 20 000 | |||||
2017-05-19 | 2017-05-17 | 4 | Troendle August J. | CHRS | Stock Option (Right to Buy) | D | 23,80 | 20 000 | 20 000 | |||||
2017-05-19 | 2017-05-17 | 4 | HEALY JAMES | CHRS | Stock Option (Right to Buy) | D | 23,80 | 20 000 | 20 000 | |||||
2017-05-19 | 2017-05-17 | 4 | LAWLIS V BRYAN | CHRS | Stock Option (Right to Buy) | D | 23,80 | 20 000 | 20 000 | |||||
2017-05-19 | 2017-05-17 | 4 | Szela Mary T | CHRS | Stock Option (Right to Buy) | D | 23,80 | 20 000 | 20 000 | |||||
2017-05-19 | 2017-05-17 | 4 | Satvat Ali J. | CHRS | Stock Option (Right to Buy) | D | 23,80 | 20 000 | 20 000 | |||||
2017-05-03 | 2017-05-01 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 19,9970 | −11 333 | −227 | 79 119 | ||||
2017-04-05 | 2017-04-03 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 20,7346 | −11 333 | −235 | 90 452 | ||||
2017-03-03 | 2017-03-01 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 24,1923 | −11 333 | −274 | 101 785 | ||||
2017-02-03 | 2017-02-01 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 27,3674 | −11 333 | −310 | 113 118 | ||||
2017-01-27 | 2017-01-25 | 4 | Viret Jean-Frederic | CHRS | Stock Option (right to buy) | D | 13,50 | −3 900 | 112 481 | |||||
2017-01-27 | 2017-01-25 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 27,0000 | −3 900 | −105 | 2 992 | ||||
2017-01-27 | 2017-01-25 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 13,5000 | 3 900 | 53 | 6 892 | ||||
2017-01-05 | 2017-01-03 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 28,6037 | −683 | −20 | 124 451 | ||||
2017-01-05 | 2017-01-03 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 27,9048 | −10 650 | −297 | 125 134 | ||||
2016-12-20 | 2016-12-19 | 4 | Viret Jean-Frederic | CHRS | Stock Option (right to buy) | D | 13,50 | −667 | 116 381 | |||||
2016-12-20 | 2016-12-19 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 13,5000 | 667 | 9 | 2 992 | ||||
2016-12-20 | 2016-12-16 | 4 | Viret Jean-Frederic | CHRS | Stock Option (right to buy) | D | 13,50 | −3 900 | 117 048 | |||||
2016-12-20 | 2016-12-16 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 28,2987 | −3 900 | −110 | 2 325 | ||||
2016-12-20 | 2016-12-16 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 13,5000 | 3 900 | 53 | 6 225 | ||||
2016-12-09 | 2016-12-08 | 4 | Wahlstrom Mats | CHRS | Common Stock, $0.0001 par value | I | 27,5243 | −46 190 | −1 271 | 0 | ||||
2016-12-09 | 2016-12-07 | 4 | Wahlstrom Mats | CHRS | Common Stock, $0.0001 par value | I | 27,5030 | −7 393 | −203 | 46 190 | ||||
2016-12-05 | 2016-12-01 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 27,5517 | −8 133 | −224 | 135 784 | ||||
2016-12-05 | 2016-12-01 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 27,0141 | −3 200 | −86 | 143 917 | ||||
2016-11-22 | 2016-11-18 | 4 | Viret Jean-Frederic | CHRS | Stock Option (right to buy) | D | 13,50 | −3 900 | 120 948 | |||||
2016-11-22 | 2016-11-18 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 28,1936 | −3 900 | −110 | 2 325 | ||||
2016-11-22 | 2016-11-18 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 13,5000 | 3 900 | 53 | 6 225 | ||||
2016-11-03 | 2016-11-01 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 27,5339 | −11 333 | −312 | 147 117 | ||||
2016-10-25 | 2016-10-21 | 4 | Viret Jean-Frederic | CHRS | Stock Option (right to buy) | D | 13,50 | −3 900 | 124 848 | |||||
2016-10-25 | 2016-10-21 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 30,6161 | −3 900 | −119 | 2 325 | ||||
2016-10-25 | 2016-10-21 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 13,5000 | 3 900 | 53 | 6 225 | ||||
2016-10-05 | 2016-10-03 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 26,2582 | −3 237 | −85 | 158 450 | ||||
2016-10-05 | 2016-10-03 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 25,4698 | −8 096 | −206 | 161 687 | ||||
2016-09-28 | 2016-09-26 | 4 | Viret Jean-Frederic | CHRS | Stock Option (right to buy) | D | 13,50 | −3 900 | 128 748 | |||||
2016-09-28 | 2016-09-26 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 29,8846 | −3 900 | −117 | 2 325 | ||||
2016-09-28 | 2016-09-26 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 13,5000 | 3 900 | 53 | 6 225 | ||||
2016-09-22 | 2016-09-21 | 4 | Lanfear Dennis M By Trust | CHRS | Common Stock, $0.0001 par value | I | 31,7500 | −50 | −2 | 1 337 566 | ||||
2016-09-22 | 2016-09-20 | 4 | Lanfear Dennis M By Trust | CHRS | Common Stock, $0.0001 par value | I | 31,7512 | −4 010 | −127 | 1 337 616 | ||||
2016-09-20 | 2016-09-16 | 4 | Lanfear Dennis M By Trust | CHRS | Common Stock, $0.0001 par value | I | 31,7928 | −2 900 | −92 | 1 341 626 | ||||
2016-09-06 | 2016-09-01 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 29,9850 | −16 999 | −510 | 169 783 | ||||
2016-08-10 | 2016-08-08 | 4 | Watler Peter K. By Wife | CHRS | Stock Option (right to buy) | I | 2,50 | −15 621 | 14 373 | |||||
2016-08-10 | 2016-08-08 | 4 | Watler Peter K. | CHRS | Stock Option (right to buy) | D | 2,08 | −40 000 | 48 503 | |||||
2016-08-10 | 2016-08-08 | 4 | Watler Peter K. By Wife | CHRS | Common Stock, $0.0001 par value | I | 30,0012 | −15 621 | −469 | 0 | ||||
2016-08-10 | 2016-08-08 | 4 | Watler Peter K. By Wife | CHRS | Common Stock, $0.0001 par value | I | 2,5005 | 15 621 | 39 | 15 621 | ||||
2016-08-10 | 2016-08-08 | 4 | Watler Peter K. | CHRS | Common Stock, $0.0001 par value | D | 30,0004 | −40 000 | −1 200 | 0 | ||||
2016-08-10 | 2016-08-08 | 4 | Watler Peter K. | CHRS | Common Stock, $0.0001 par value | D | 2,0838 | 40 000 | 83 | 40 000 | ||||
2016-08-10 | 2016-08-08 | 4 | FMR LLC / Fidelity Management & Research | CHRS | Common Stock | I | 29,8700 | −10 000 | −299 | 361 594 | ||||
2016-08-10 | 2016-08-08 | 4 | FMR LLC / Fidelity Management & Research | CHRS | Common Stock | I | 29,8600 | −84 976 | −2 537 | 371 594 | ||||
2016-08-10 | 2016-08-08 | 4 | FMR LLC / Fidelity Management & Research | CHRS | Common Stock | I | 29,8400 | −1 349 | −40 | 456 570 | ||||
2016-08-10 | 2016-08-08 | 4 | FMR LLC / Fidelity Management & Research | CHRS | Common Stock | I | 29,9200 | −1 100 | −33 | 457 919 | ||||
2016-08-10 | 2016-08-08 | 4 | FMR LLC / Fidelity Management & Research | CHRS | Common Stock | I | 29,8900 | −2 100 | −63 | 459 019 | ||||
2016-08-10 | 2016-08-08 | 4 | FMR LLC / Fidelity Management & Research | CHRS | Common Stock | I | 29,8900 | −475 | −14 | 461 119 | ||||
2016-08-08 | 2016-08-05 | 4 | FMR LLC / Fidelity Management & Research | CHRS | Common Stock | I | 28,7800 | −25 000 | −720 | 461 594 | ||||
2016-08-08 | 2016-08-04 | 4 | FMR LLC / Fidelity Management & Research | CHRS | Common Stock | I | 27,9500 | −100 | −3 | 486 594 | ||||
2016-08-08 | 2016-08-04 | 4 | FMR LLC / Fidelity Management & Research | CHRS | Common Stock | I | 27,8700 | −100 | −3 | 486 694 | ||||
2016-08-08 | 2016-08-04 | 4 | FMR LLC / Fidelity Management & Research | CHRS | Common Stock | I | 27,9700 | −200 | −6 | 486 794 | ||||
2016-08-08 | 2016-08-04 | 4 | FMR LLC / Fidelity Management & Research | CHRS | Common Stock | I | 28,1600 | −23 200 | −653 | 486 994 | ||||
2016-08-03 | 2016-08-01 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 25,5390 | −11 333 | −289 | 186 782 | ||||
2016-07-25 | 2016-07-21 | 4 | Watler Peter K. | CHRS | Stock Option (right to buy) | D | 2,08 | −3 991 | 88 503 | |||||
2016-07-25 | 2016-07-21 | 4 | Watler Peter K. | CHRS | Common Stock, $0.0001 par value | D | 26,4814 | −700 | −19 | 0 | ||||
2016-07-25 | 2016-07-21 | 4 | Watler Peter K. | CHRS | Common Stock, $0.0001 par value | D | 26,0513 | −3 291 | −86 | 700 | ||||
2016-07-25 | 2016-07-21 | 4 | Watler Peter K. | CHRS | Common Stock, $0.0001 par value | D | 2,0838 | 3 991 | 8 | 3 991 | ||||
2016-07-22 | 2016-07-20 | 4 | Watler Peter K. By Wife | CHRS | Stock Option (right to buy) | I | 1,42 | −23 741 | 16 247 | |||||
2016-07-22 | 2016-07-20 | 4 | Watler Peter K. | CHRS | Stock Option (right to buy) | D | 2,08 | −50 000 | 92 494 | |||||
2016-07-22 | 2016-07-20 | 4 | Watler Peter K. By Wife | CHRS | Common Stock, $0.0001 par value | I | 25,0000 | −23 741 | −594 | 0 | ||||
2016-07-22 | 2016-07-20 | 4 | Watler Peter K. By Wife | CHRS | Common Stock, $0.0001 par value | I | 1,4170 | 23 741 | 34 | 23 741 | ||||
2016-07-22 | 2016-07-20 | 4 | Watler Peter K. | CHRS | Common Stock, $0.0001 par value | D | 25,0242 | −50 000 | −1 251 | 0 | ||||
2016-07-22 | 2016-07-20 | 4 | Watler Peter K. | CHRS | Common Stock, $0.0001 par value | D | 2,0838 | 50 000 | 104 | 50 000 | ||||
2016-07-13 | 2016-07-11 | 4 | Watler Peter K. By Wife | CHRS | Stock Option (right to buy) | I | 2,08 | −43 495 | 0 | |||||
2016-07-13 | 2016-07-11 | 4 | Watler Peter K. By Wife | CHRS | Common Stock, $0.0001 par value | I | 20,0237 | −43 495 | −871 | 0 | ||||
2016-07-13 | 2016-07-11 | 4 | Watler Peter K. By Wife | CHRS | Common Stock, $0.0001 par value | I | 2,0838 | 43 495 | 91 | 43 495 | ||||
2016-07-08 | 2016-07-06 | 4 | Viret Jean-Frederic | CHRS | Stock Option (Right to Buy) | D | 13,50 | −1 925 | 132 648 | |||||
2016-07-08 | 2016-07-06 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 13,5000 | 1 925 | 26 | 2 325 | ||||
2016-07-05 | 2016-07-01 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 16,8882 | −4 250 | −72 | 198 115 | ||||
2016-06-03 | 2016-06-01 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 18,6729 | −4 250 | −79 | 202 365 | ||||
2016-05-26 | 2015-08-18 | 4/A | Wahlstrom Mats | CHRS | Common Stock, $0.0001 par value | I | 33,5020 | −6 372 | −213 | 578 528 | ||||
2016-05-26 | 2016-02-29 | 4/A | Wahlstrom Mats | CHRS | 8.2% Senior Convertible Notes due 2022 | I | 22,3500 | 1 000 000 | 22 350 | 1 000 000 | ||||
2016-05-26 | 2016-05-24 | 4 | HEALY JAMES | CHRS | Stock Option (Right to Buy) | D | 18,28 | 10 000 | 10 000 | |||||
2016-05-26 | 2016-05-24 | 4 | Szela Mary T | CHRS | Stock Option (Right to Buy) | D | 18,28 | 10 000 | 10 000 | |||||
2016-05-26 | 2016-05-24 | 4 | Wahlstrom Mats | CHRS | Stock Option (Right to Buy) | D | 18,28 | 10 000 | 10 000 | |||||
2016-05-26 | 2016-05-24 | 4 | LAWLIS V BRYAN | CHRS | Stock Option (Right to Buy) | D | 18,28 | 10 000 | 10 000 | |||||
2016-05-26 | 2016-05-24 | 4 | Satvat Ali J. | CHRS | Stock Option (Right to Buy) | D | 18,28 | 10 000 | 10 000 | |||||
2016-05-26 | 2016-05-24 | 4 | Richards Christos | CHRS | Stock Option (Right to Buy) | D | 18,28 | 10 000 | 10 000 | |||||
2016-05-26 | 2016-05-24 | 4 | Troendle August J. | CHRS | Stock Option (Right to Buy) | D | 18,28 | 10 000 | 10 000 | |||||
2016-05-19 | 2016-05-17 | 4 | Watler Peter K. By Wife | CHRS | Stock Option (right to buy) | I | 2,08 | −12 000 | 43 495 | |||||
2016-05-19 | 2016-05-17 | 4 | Watler Peter K. By Wife | CHRS | Common Stock, $0.0001 par value | I | 20,0000 | −12 000 | −240 | 0 | ||||
2016-05-19 | 2016-05-17 | 4 | Watler Peter K. By Wife | CHRS | Common Stock, $0.0001 par value | I | 2,0838 | 12 000 | 25 | 12 000 | ||||
2016-05-13 | 2016-05-11 | 4 | Viret Jean-Frederic | CHRS | Stock Option (Right to Buy) | D | 17,17 | 78 472 | 78 472 | |||||
2016-05-13 | 2016-05-11 | 4 | FINCK BARBARA K | CHRS | Stock Option (Right to Buy) | D | 17,17 | 78 472 | 78 472 | |||||
2016-05-13 | 2016-05-11 | 4 | Lanfear Dennis M | CHRS | Stock Option (Right to Buy) | D | 17,17 | 323 889 | 323 889 | |||||
2016-05-13 | 2016-05-11 | 4 | Herman Alan C. | CHRS | Stock Option (Right to Buy) | D | 17,17 | −69 236 | 69 236 | |||||
2016-05-13 | 2016-05-11 | 4 | Watler Peter K. | CHRS | Stock Option (Right to Buy) | D | 17,17 | 78 472 | 78 472 | |||||
2016-05-04 | 2015-04-01 | 4/A | Watler Peter K. By Wife | CHRS | Stock Option (Right to Buy) | I | 29,00 | 37 500 | 37 500 | |||||
2016-05-04 | 2015-04-01 | 4/A | Watler Peter K. | CHRS | Stock Option (Right to Buy) | D | 29,00 | 100 000 | 100 000 | |||||
2016-05-04 | 2016-05-02 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 19,6346 | −552 | −11 | 206 615 | ||||
2016-05-04 | 2016-05-02 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 19,1329 | −3 698 | −71 | 207 167 | ||||
2016-05-04 | 2016-05-02 | 4 | Watler Peter K. By Wife | CHRS | Stock Option (right to buy) | I | 2,08 | −1 493 | 55 495 | |||||
2016-05-04 | 2016-05-02 | 4 | Watler Peter K. By Wife | CHRS | Common Stock, $0.0001 par value | I | 20,0000 | −1 493 | −30 | 0 | ||||
2016-05-04 | 2016-05-02 | 4 | Watler Peter K. By Wife | CHRS | Common Stock, $0.0001 par value | I | 2,0838 | 1 493 | 3 | 1 493 | ||||
2016-05-04 | 2015-11-20 | 4 | Watler Peter K. By Wife | CHRS | Stock Option (right to buy) | I | 1,42 | −20 000 | 39 988 | |||||
2016-05-04 | 2015-11-20 | 4 | Watler Peter K. By Wife | CHRS | Common Stock, $0.0001 par value | I | 27,4089 | −20 000 | −548 | 0 | ||||
2016-05-04 | 2015-11-20 | 4 | Watler Peter K. By Wife | CHRS | Common Stock, $0.0001 par value | I | 1,4170 | 20 000 | 28 | 20 000 | ||||
2016-04-06 | 2016-04-01 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 21,8871 | −977 | −21 | 210 865 | ||||
2016-04-06 | 2016-04-01 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 21,1974 | −3 273 | −69 | 211 842 | ||||
2016-03-30 | 2016-03-28 | 4 | Viret Jean-Frederic | CHRS | Stock Option (Right to Buy) | D | 13,50 | −400 | 134 573 | |||||
2016-03-30 | 2016-03-28 | 4 | Viret Jean-Frederic | CHRS | Common Stock, $0.0001 par value | D | 13,5000 | 400 | 5 | 400 | ||||
2016-03-11 | 2016-02-29 | 4 | Wahlstrom Mats | CHRS | 8.2% Senior Convertible Notes due 2022 | I | 22,3500 | |||||||
2016-03-11 | 2016-02-29 | 4 | Troendle August J. | CHRS | 8.2% Senior Convertible Notes due 2022 | I | 22,3500 | |||||||
2016-03-03 | 2016-03-02 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 15,3152 | −6 015 | −92 | 215 115 | ||||
2016-03-03 | 2016-03-01 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 15,0026 | −485 | −7 | 221 130 | ||||
2016-02-11 | 2016-02-09 | 4 | Troendle August J. | CHRS | Stock Option (Right to Buy) | D | 0,42 | −8 124 | 0 | |||||
2016-02-11 | 2016-02-09 | 4 | Troendle August J. | CHRS | Common Stock, $0.0001 par value | D | 0,4168 | 8 124 | 3 | 29 994 | ||||
2016-02-09 | 2016-02-05 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 15,0202 | −2 000 | −30 | 221 615 | ||||
2016-01-06 | 2016-01-04 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 22,3567 | −300 | −7 | 223 615 | ||||
2016-01-06 | 2016-01-04 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 21,4038 | −3 950 | −85 | 223 915 | ||||
2015-12-28 | 2015-12-23 | 4 | Herman Alan C. | CHRS | Stock Option (right to buy) | D | 0,42 | −16 000 | 32 862 | |||||
2015-12-28 | 2015-12-23 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 0,4168 | 16 000 | 7 | 227 865 | ||||
2015-12-02 | 2015-12-01 | 4 | Herman Alan C. | CHRS | Stock Option (right to buy) | D | 0,42 | −8 499 | 48 862 | |||||
2015-12-02 | 2015-12-01 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 29,6734 | −8 933 | −265 | 211 865 | ||||
2015-12-02 | 2015-12-01 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 28,8017 | −2 400 | −69 | 220 798 | ||||
2015-12-02 | 2015-12-01 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 0,4168 | 8 499 | 4 | 223 198 | ||||
2015-12-02 | 2015-11-30 | 4 | Lanfear Dennis M By Trust | CHRS | Common Stock, $0.0001 par value | I | 31,7500 | −400 | −13 | 1 344 526 | ||||
2015-11-16 | 2015-11-13 | 4 | Richards Christos | CHRS | Common Stock, $0.0001 par value | D | 27,9290 | −4 012 | −112 | 63 836 | ||||
2015-11-16 | 2015-11-13 | 4 | Richards Christos | CHRS | Common Stock, $0.0001 par value | D | 27,3762 | −7 988 | −219 | 67 848 | ||||
2015-11-16 | 2015-11-12 | 4 | Richards Christos | CHRS | Common Stock, $0.0001 par value | D | 27,2309 | −3 000 | −82 | 75 836 | ||||
2015-11-04 | 2015-11-02 | 4 | Herman Alan C. | CHRS | Stock Option (right to buy) | D | 0,42 | −18 416 | 57 361 | |||||
2015-11-04 | 2015-11-02 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 29,2508 | −1 900 | −56 | 214 699 | ||||
2015-11-04 | 2015-11-02 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 28,6457 | −16 516 | −473 | 216 599 | ||||
2015-11-04 | 2015-11-02 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 0,4168 | 18 416 | 8 | 233 115 | ||||
2015-10-29 | 3 | FMR LLC / Fidelity Management & Research Impresa Fund III Limited Partnership | CHRS | Common Stock | I | 910 382 | ||||||||
2015-10-29 | 3 | FMR LLC / Fidelity Management & Research F-Prime Inc. | CHRS | Common Stock | I | 510 722 | ||||||||
2015-10-29 | 3 | FMR LLC / Fidelity Management & Research Beacon Bioventures Fund III Limited Partnership | CHRS | Common Stock | I | 619 672 | ||||||||
2015-10-29 | 3 | FMR LLC / Fidelity Management & Research Impresa Fund III Limited Partnership | CHRS | Common Stock | I | 910 382 | ||||||||
2015-10-29 | 3 | FMR LLC / Fidelity Management & Research F-Prime Inc. | CHRS | Common Stock | I | 510 722 | ||||||||
2015-10-29 | 3 | FMR LLC / Fidelity Management & Research Beacon Bioventures Fund III Limited Partnership | CHRS | Common Stock | I | 619 672 | ||||||||
2015-10-05 | 2015-10-01 | 4 | Herman Alan C. | CHRS | Stock Option (right to buy) | D | 0,42 | −4 250 | 75 777 | |||||
2015-10-05 | 2015-10-01 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 19,5056 | −900 | −18 | 214 699 | ||||
2015-10-05 | 2015-10-01 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 18,8326 | −3 350 | −63 | 215 599 | ||||
2015-10-05 | 2015-10-01 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 0,4168 | 4 250 | 2 | 218 949 | ||||
2015-09-03 | 2015-09-01 | 4 | Herman Alan C. | CHRS | Stock Option (right to buy) | D | 0,42 | −11 333 | 80 027 | |||||
2015-09-03 | 2015-09-01 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 27,5674 | −5 309 | −146 | 214 699 | ||||
2015-09-03 | 2015-09-01 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 27,2307 | −6 024 | −164 | 220 008 | ||||
2015-09-03 | 2015-09-01 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 0,4168 | 11 333 | 5 | 226 032 | ||||
2015-08-21 | 3 | FMR LLC / Fidelity Management & Research Impresa Fund III Limited Partnership | CHRS | Common Stock | I | 910 382 | ||||||||
2015-08-21 | 3 | FMR LLC / Fidelity Management & Research Beacon Bioventures Fund III Limited Partnership | CHRS | Common Stock | I | 619 672 | ||||||||
2015-08-21 | 3 | FMR LLC / Fidelity Management & Research Beacon Bioventures Fund III Limited Partnership | CHRS | Common Stock | I | 619 672 | ||||||||
2015-08-21 | 3 | FMR LLC / Fidelity Management & Research Fidelity Biosciences Corporation | CHRS | Common Stock | I | 510 722 | ||||||||
2015-08-21 | 3 | FMR LLC / Fidelity Management & Research Fidelity Biosciences Corporation | CHRS | Common Stock | I | 510 722 | ||||||||
2015-08-21 | 3 | FMR LLC / Fidelity Management & Research Impresa Fund III Limited Partnership | CHRS | Common Stock | I | 910 382 | ||||||||
2015-08-20 | 2015-08-18 | 4 | Wahlstrom Mats | CHRS | Common Stock, $0.0001 par value | I | 33,5020 | −6 373 | −214 | 578 527 | ||||
2015-08-19 | 2015-08-17 | 4 | Wahlstrom Mats | CHRS | Common Stock, $0.0001 par value | I | 33,9094 | −8 028 | −272 | 584 900 | ||||
2015-08-18 | 2015-08-14 | 4 | Wahlstrom Mats | CHRS | Common Stock, $0.0001 par value | I | 34,2363 | −116 554 | −3 990 | 592 928 | ||||
2015-08-05 | 2015-08-03 | 4 | Herman Alan C. | CHRS | Stock Option (right to buy) | D | 0,42 | −14 166 | 91 360 | |||||
2015-08-05 | 2015-08-03 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 34,8308 | −14 166 | −493 | 214 699 | ||||
2015-08-05 | 2015-08-03 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 0,4168 | 14 166 | 6 | 228 865 | ||||
2015-08-03 | 2015-07-30 | 4 | Troendle August J. | CHRS | Common Stock, $0.0001 par value | I | 35,1544 | −860 | −30 | 268 428 | ||||
2015-08-03 | 2015-07-30 | 4 | Troendle August J. | CHRS | Common Stock, $0.0001 par value | I | 34,0896 | −24 809 | −846 | 269 288 | ||||
2015-08-03 | 2015-07-30 | 4 | Troendle August J. | CHRS | Common Stock, $0.0001 par value | I | 33,7672 | −62 442 | −2 108 | 294 097 | ||||
2015-08-03 | 2015-07-30 | 4 | Troendle August J. | CHRS | Common Stock, $0.0001 par value | I | 32,2244 | −1 889 | −61 | 356 539 | ||||
2015-08-03 | 2015-07-30 | 4 | Troendle August J. | CHRS | Common Stock, $0.0001 par value | I | 35,1539 | −2 370 | −83 | 1 642 492 | ||||
2015-08-03 | 2015-07-30 | 4 | Troendle August J. | CHRS | Common Stock, $0.0001 par value | I | 34,0897 | −68 941 | −2 350 | 1 644 862 | ||||
2015-08-03 | 2015-07-30 | 4 | Troendle August J. | CHRS | Common Stock, $0.0001 par value | I | 33,7673 | −173 440 | −5 857 | 1 713 803 | ||||
2015-08-03 | 2015-07-30 | 4 | Troendle August J. | CHRS | Common Stock, $0.0001 par value | I | 32,2243 | −5 249 | −169 | 1 887 243 | ||||
2015-06-16 | 2015-06-15 | 4 | Troendle August J. | CHRS | Common Stock, $0.0001 par value | I | 27,0753 | −2 376 | −64 | 1 892 492 | ||||
2015-06-16 | 2015-06-15 | 4 | Troendle August J. | CHRS | Common Stock, $0.0001 par value | I | 26,6167 | −111 606 | −2 971 | 1 894 868 | ||||
2015-06-16 | 2015-06-12 | 4 | Troendle August J. | CHRS | Common Stock, $0.0001 par value | I | 27,2893 | −1 851 | −51 | 2 006 474 | ||||
2015-06-16 | 2015-06-12 | 4 | Troendle August J. | CHRS | Common Stock, $0.0001 par value | I | 26,7223 | −134 167 | −3 585 | 2 008 325 | ||||
2015-05-27 | 2015-04-01 | 4/A | Szela Mary T | CHRS | Stock Option (Right to Buy) | D | 29,00 | 20 000 | 20 000 | |||||
2015-05-27 | 2015-04-01 | 4/A | Satvat Ali J. | CHRS | Stock Option (Right to Buy) | D | 29,00 | 20 000 | 20 000 | |||||
2015-05-27 | 2015-04-01 | 4/A | Wahlstrom Mats | CHRS | Stock Option (Right to Buy) | D | 29,00 | 75 000 | 75 000 | |||||
2015-05-27 | 2015-04-01 | 4/A | Wahlstrom Mats | CHRS | Stock Option (Right to Buy) | D | 29,00 | 20 000 | 20 000 | |||||
2015-05-27 | 2015-04-01 | 4/A | Richards Christos | CHRS | Stock Option (Right to Buy) | D | 29,00 | 20 000 | 20 000 | |||||
2015-05-27 | 2015-04-01 | 4/A | HEALY JAMES | CHRS | Stock Option (Right to Buy) | D | 29,00 | 25 000 | 25 000 | |||||
2015-05-27 | 2015-04-01 | 4/A | HEALY JAMES | CHRS | Stock Option (Right to Buy) | D | 29,00 | 20 000 | 20 000 | |||||
2015-05-27 | 2015-03-18 | 4/A | HEALY JAMES | CHRS | Common Stock, $0.0001 par value | I | 239 364 | 2 893 221 | ||||||
2015-05-27 | 2015-03-18 | 4/A | HEALY JAMES | CHRS | Common Stock, $0.0001 par value | D | 33 | 92 | ||||||
2015-05-27 | 2015-03-10 | 4/A | HEALY JAMES | CHRS | Common Stock, $0.0001 par value | I | 96 098 | 2 653 857 | ||||||
2015-05-27 | 2015-03-10 | 4/A | HEALY JAMES | CHRS | Common Stock, $0.0001 par value | D | 12 | 59 | ||||||
2015-05-27 | 2015-04-01 | 4/A | LAWLIS V BRYAN | CHRS | Stock Option (Right to Buy) | D | 29,00 | 25 000 | 25 000 | |||||
2015-05-27 | 2015-04-01 | 4/A | LAWLIS V BRYAN | CHRS | Stock Option (Right to Buy) | D | 29,00 | 6 250 | 6 250 | |||||
2015-05-27 | 2015-04-01 | 4/A | LAWLIS V BRYAN | CHRS | Stock Option (Right to Buy) | D | 29,00 | 20 000 | 20 000 | |||||
2015-05-27 | 2015-04-01 | 4/A | Troendle August J. | CHRS | Stock Option (Right to Buy) | D | 29,00 | 20 000 | 20 000 | |||||
2015-05-26 | 2015-05-21 | 4 | Lanfear Dennis M | CHRS | Stock Option (Right to Buy) | D | 25,26 | 35 000 | 35 000 | |||||
2015-04-03 | 2015-04-01 | 4 | Viret Jean-Frederic | CHRS | Stock Option (Right to Buy) | D | 29,00 | 100 000 | 100 000 | |||||
2015-04-03 | 2015-04-01 | 4 | FINCK BARBARA K | CHRS | Stock Option (Right to Buy) | D | 29,00 | 100 000 | 100 000 | |||||
2015-04-03 | 2015-04-01 | 4 | HEALY JAMES | CHRS | Stock Option (Right to Buy) | D | 29,00 | 25 000 | 25 000 | |||||
2015-04-03 | 2015-04-01 | 4 | HEALY JAMES | CHRS | Stock Option (Right to Buy) | D | 29,00 | 20 000 | 20 000 | |||||
2015-04-03 | 2015-03-18 | 4 | HEALY JAMES | CHRS | Common Stock, $0.0001 par value | I | 239 364 | 2 893 221 | ||||||
2015-04-03 | 2015-03-18 | 4 | HEALY JAMES | CHRS | Common Stock, $0.0001 par value | D | 33 | 92 | ||||||
2015-04-03 | 2015-03-10 | 4 | HEALY JAMES | CHRS | Common Stock, $0.0001 par value | I | 96 098 | 2 653 857 | ||||||
2015-04-03 | 2015-03-10 | 4 | HEALY JAMES | CHRS | Common Stock, $0.0001 par value | D | 12 | 59 | ||||||
2015-04-03 | 2015-04-01 | 4 | Wahlstrom Mats | CHRS | Stock Option (Right to Buy) | D | 29,00 | 75 000 | 75 000 | |||||
2015-04-03 | 2015-04-01 | 4 | Wahlstrom Mats | CHRS | Stock Option (Right to Buy) | D | 29,00 | 20 000 | 20 000 | |||||
2015-04-03 | 2015-04-01 | 4 | LAWLIS V BRYAN | CHRS | Stock Option (Right to Buy) | D | 29,00 | 25 000 | 25 000 | |||||
2015-04-03 | 2015-04-01 | 4 | LAWLIS V BRYAN | CHRS | Stock Option (Right to Buy) | D | 29,00 | 6 250 | 6 250 | |||||
2015-04-03 | 2015-04-01 | 4 | LAWLIS V BRYAN | CHRS | Stock Option (Right to Buy) | D | 29,00 | 20 000 | 20 000 | |||||
2015-04-03 | 2015-04-02 | 4 | Lanfear Dennis M | CHRS | Stock Option (Right to Buy) | D | 29,00 | 150 000 | 150 000 | |||||
2015-04-03 | 2015-04-02 | 4 | Lanfear Dennis M | CHRS | Stock Option (Right to Buy) | D | 29,00 | 250 000 | 250 000 | |||||
2015-04-03 | 2015-04-01 | 4 | Szela Mary T | CHRS | Stock Option (Right to Buy) | D | 29,00 | 20 000 | 20 000 | |||||
2015-04-03 | 2015-04-01 | 4 | Satvat Ali J. | CHRS | Stock Option (Right to Buy) | D | 29,00 | 20 000 | 20 000 | |||||
2015-04-03 | 2015-04-01 | 4 | Richards Christos | CHRS | Stock Option (Right to Buy) | D | 29,00 | 20 000 | 20 000 | |||||
2015-04-03 | 2015-04-01 | 4 | Troendle August J. | CHRS | Stock Option (Right to Buy) | D | 29,00 | 20 000 | 20 000 | |||||
2015-04-03 | 2015-04-01 | 4 | Herman Alan C. | CHRS | Stock Option (Right to Buy) | D | 29,00 | 50 000 | 50 000 | |||||
2015-04-03 | 2015-04-01 | 4 | Watler Peter K. | CHRS | Stock Option (Right to Buy) | D | 29,00 | 100 000 | 100 000 | |||||
2015-03-18 | 2015-03-18 | 4 | Lanfear Dennis M By LLC | CHRS | Common Stock, $0.0001 par value | I | 13 | 86 965 | ||||||
2015-03-18 | 2015-03-18 | 4 | Lanfear Dennis M | CHRS | Common Stock, $0.0001 par value | D | 2 084 | 71 635 | ||||||
2015-03-18 | 2015-03-18 | 4 | Lanfear Dennis M By Trust | CHRS | Common Stock, $0.0001 par value | I | 2 206 | 1 344 926 | ||||||
2015-03-12 | 2015-03-10 | 4 | Lanfear Dennis M By LLC | CHRS | Common Stock, $0.0001 par value | I | 4 | 86 952 | ||||||
2015-03-12 | 2015-03-10 | 4 | Lanfear Dennis M | CHRS | Common Stock, $0.0001 par value | D | 828 | 69 551 | ||||||
2015-03-12 | 2015-03-10 | 4 | Lanfear Dennis M By Trust | CHRS | Common Stock, $0.0001 par value | I | 799 | 1 342 720 | ||||||
2015-01-02 | 2014-12-31 | 4 | Satvat Ali J. | CHRS | Stock Option (Right to Buy) | D | 16,32 | 15 000 | 15 000 | |||||
2015-01-02 | 2014-12-31 | 4 | LAWLIS V BRYAN | CHRS | Stock Option (Right to Buy) | D | 16,32 | 15 000 | 15 000 | |||||
2014-12-24 | 2014-12-23 | 4 | Lanfear Dennis M By Trust | CHRS | Common Stock, $0.0001 par value | I | −20 000 | 1 341 921 | ||||||
2014-12-24 | 2014-12-23 | 4 | Wahlstrom Mats | CHRS | Common Stock, $0.0001 par value | I | 114 639 | 709 482 | ||||||
2014-12-24 | 2014-12-23 | 4 | Wahlstrom Mats | CHRS | Common Stock, $0.0001 par value | I | −221 538 | 0 | ||||||
2014-11-14 | 2014-11-12 | 4 | KKR Biosimilar L.P. | CHRS | Series C Preferred Stock | I | −2 499 499 | 0 | ||||||
2014-11-14 | 2014-11-12 | 4 | KKR Biosimilar L.P. | CHRS | Common Stock | I | 2 499 499 | 2 499 499 | ||||||
2014-11-12 | 2014-11-06 | 4 | LAWLIS V BRYAN | CHRS | Stock Option (Right to Buy) | D | 13,50 | 14 997 | 14 997 | |||||
2014-11-12 | 2014-11-06 | 4 | Viret Jean-Frederic | CHRS | Stock Option (Right to Buy) | D | 13,50 | 134 973 | 134 973 | |||||
2014-11-12 | 2014-11-12 | 4 | FINCK BARBARA K | CHRS | Series C Preferred Stock | D | −5 286 | 0 | ||||||
2014-11-12 | 2014-11-12 | 4 | FINCK BARBARA K | CHRS | Series B Preferred Stock | D | −21 505 | 0 | ||||||
2014-11-12 | 2014-11-12 | 4 | FINCK BARBARA K | CHRS | Common Stock, $0.0001 par value | D | 5 286 | 26 791 | ||||||
2014-11-12 | 2014-11-12 | 4 | FINCK BARBARA K | CHRS | Common Stock, $0.0001 par value | D | 21 505 | 21 505 | ||||||
2014-11-12 | 2014-11-12 | 4 | Lanfear Dennis M By LLC | CHRS | Series C Preferred Stock | I | −5 286 | 0 | ||||||
2014-11-12 | 2014-11-12 | 4 | Lanfear Dennis M By LLC | CHRS | Series B Preferred Stock | I | −21 527 | 0 | ||||||
2014-11-12 | 2014-11-12 | 4 | Lanfear Dennis M By LLC | CHRS | Series A Preferred Stock | I | −60 135 | 0 | ||||||
2014-11-12 | 2014-11-12 | 4 | Lanfear Dennis M By Trust | CHRS | Series B Preferred Stock | I | −3 193 | 0 | ||||||
2014-11-12 | 2014-11-12 | 4 | Lanfear Dennis M | CHRS | Series B Preferred Stock | D | −17 734 | 0 | ||||||
2014-11-12 | 2014-11-12 | 4 | Lanfear Dennis M | CHRS | Series B Preferred Stock | D | 0,0167 | 3 225 | 0 | 17 734 | ||||
2014-11-12 | 2014-11-12 | 4 | Lanfear Dennis M | CHRS | Warrant to Purchase Series B Preferred Stock | D | 0,02 | −3 225 | 0 | |||||
2014-11-12 | 2014-11-12 | 4 | Lanfear Dennis M By LLC | CHRS | Series A Preferred Stock | I | 1,2503 | 19 976 | 25 | 60 135 | ||||
2014-11-12 | 2014-11-12 | 4 | Lanfear Dennis M By LLC | CHRS | Warrant to Purchase Series A Preferred Stock | I | 1,25 | −19 976 | 0 | |||||
2014-11-12 | 2014-11-12 | 4 | Lanfear Dennis M By LLC | CHRS | Common Stock, $0.0001 par value | I | 5 286 | 86 948 | ||||||
2014-11-12 | 2014-11-12 | 4 | Lanfear Dennis M By LLC | CHRS | Common Stock, $0.0001 par value | I | 21 527 | 81 662 | ||||||
2014-11-12 | 2014-11-12 | 4 | Lanfear Dennis M By LLC | CHRS | Common Stock, $0.0001 par value | I | 60 135 | 60 135 | ||||||
2014-11-12 | 2014-11-12 | 4 | Lanfear Dennis M By Trust | CHRS | Common Stock, $0.0001 par value | I | 3 193 | 1 361 921 | ||||||
2014-11-12 | 2014-11-12 | 4 | Lanfear Dennis M | CHRS | Common Stock, $0.0001 par value | D | 17 734 | 68 723 | ||||||
2014-11-12 | 2014-11-12 | 4 | Daiichi Sankyo Company, LTD | CHRS | Series B Preferred Stock | D | −2 867 426 | 0 | ||||||
2014-11-12 | 2014-11-12 | 4 | Daiichi Sankyo Company, LTD | CHRS | Common Stock, $0.0001 par value | D | 2 867 426 | 2 867 426 | ||||||
2014-11-12 | 2014-11-12 | 4 | HEALY JAMES | CHRS | Series C Preferred Stock | I | −149 970 | 0 | ||||||
2014-11-12 | 2014-11-12 | 4 | HEALY JAMES | CHRS | Series B Preferred Stock | I | −1 846 890 | 0 | ||||||
2014-11-12 | 2014-11-12 | 4 | HEALY JAMES | CHRS | Series B Preferred Stock | D | −47 | 0 | ||||||
2014-11-12 | 2014-11-12 | 4 | HEALY JAMES | CHRS | Common Stock, $0.0001 par value | I | 13,5000 | 425 926 | 5 750 | 2 557 759 | ||||
2014-11-12 | 2014-11-12 | 4 | HEALY JAMES | CHRS | Common Stock, $0.0001 par value | I | 149 970 | 2 131 833 | ||||||
2014-11-12 | 2014-11-12 | 4 | HEALY JAMES | CHRS | Common Stock, $0.0001 par value | I | 1 846 890 | 1 981 863 | ||||||
2014-11-12 | 2014-11-12 | 4 | HEALY JAMES | CHRS | Common Stock, $0.0001 par value | D | 47 | 47 | ||||||
2014-11-12 | 2014-11-12 | 4 | Wahlstrom Mats | CHRS | Series C Preferred Stock | I | −10 572 | 0 | ||||||
2014-11-12 | 2014-11-12 | 4 | Wahlstrom Mats | CHRS | Series C Preferred Stock | I | −43 011 | 0 | ||||||
2014-11-12 | 2014-11-12 | 4 | Wahlstrom Mats | CHRS | Series C Preferred Stock | I | −79 950 | 0 | ||||||
2014-11-12 | 2014-11-12 | 4 | Wahlstrom Mats | CHRS | Series B Preferred Stock | I | −514 893 | 0 | ||||||
2014-11-12 | 2014-11-12 | 4 | Wahlstrom Mats | CHRS | Series B Preferred Stock | I | −26 649 | 0 | ||||||
2014-11-12 | 2014-11-12 | 4 | Wahlstrom Mats | CHRS | Series B Preferred Stock | I | −194 889 | 0 | ||||||
2014-11-12 | 2014-11-12 | 4 | Wahlstrom Mats | CHRS | Common Stock, $0.0001 par value | I | 10 572 | 53 583 | ||||||
2014-11-12 | 2014-11-12 | 4 | Wahlstrom Mats | CHRS | Common Stock, $0.0001 par value | I | 43 011 | 43 011 | ||||||
2014-11-12 | 2014-11-12 | 4 | Wahlstrom Mats | CHRS | Common Stock, $0.0001 par value | I | 79 950 | 594 843 | ||||||
2014-11-12 | 2014-11-12 | 4 | Wahlstrom Mats | CHRS | Common Stock, $0.0001 par value | I | 514 893 | 514 893 | ||||||
2014-11-12 | 2014-11-12 | 4 | Wahlstrom Mats | CHRS | Common Stock, $0.0001 par value | I | 26 649 | 221 538 | ||||||
2014-11-12 | 2014-11-12 | 4 | Wahlstrom Mats | CHRS | Common Stock, $0.0001 par value | I | 194 889 | 194 889 | ||||||
2014-11-12 | 2014-11-12 | 4 | Richards Christos | CHRS | Series C Preferred Stock | D | −2 624 | 0 | ||||||
2014-11-12 | 2014-11-12 | 4 | Richards Christos | CHRS | Series B Preferred Stock | D | −12 672 | 0 | ||||||
2014-11-12 | 2014-11-12 | 4 | Richards Christos | CHRS | Series A Preferred Stock | D | −39 991 | 0 | ||||||
2014-11-12 | 2014-11-12 | 4 | Richards Christos | CHRS | Series B Preferred Stock | D | −1 | 12 672 | ||||||
2014-11-12 | 2014-11-12 | 4 | Richards Christos | CHRS | Series B Preferred Stock | D | 0,0167 | 429 | 0 | 12 673 | ||||
2014-11-12 | 2014-11-12 | 4 | Richards Christos | CHRS | Warrant to Purchase Series B Preferred Stock | D | 0,02 | −429 | 0 | |||||
2014-11-12 | 2014-11-12 | 4 | Richards Christos | CHRS | Warrant to Purchase Common Stock | D | 1,67 | −26 505 | 0 | |||||
2014-11-12 | 2014-11-12 | 4 | Richards Christos | CHRS | Common Stock, $0.0001 par value | D | 2 624 | 78 836 | ||||||
2014-11-12 | 2014-11-12 | 4 | Richards Christos | CHRS | Common Stock, $0.0001 par value | D | 12 672 | 76 212 | ||||||
2014-11-12 | 2014-11-12 | 4 | Richards Christos | CHRS | Common Stock, $0.0001 par value | D | 39 991 | 63 540 | ||||||
2014-11-12 | 2014-11-12 | 4 | Richards Christos | CHRS | Common Stock, $0.0001 par value | D | −2 956 | 23 549 | ||||||
2014-11-12 | 2014-11-12 | 4 | Richards Christos | CHRS | Common Stock, $0.0001 par value | D | 1,6670 | 26 505 | 44 | 26 505 | ||||
2014-11-12 | 2014-11-12 | 4 | Troendle August J. | CHRS | Series B Preferred Stock | I | −358 428 | 0 | ||||||
2014-11-12 | 2014-11-12 | 4 | Troendle August J. | CHRS | Series C Preferred Stock | I | −266 502 | 0 | ||||||
2014-11-12 | 2014-11-12 | 4 | Troendle August J. | CHRS | Series B Preferred Stock | I | −1 556 055 | 0 | ||||||
2014-11-12 | 2014-11-12 | 4 | Troendle August J. | CHRS | Series A Preferred Stock | I | −319 935 | 0 | ||||||
2014-11-12 | 2014-11-12 | 4 | Troendle August J. | CHRS | Series B Preferred Stock | I | 0,0167 | 107 528 | 2 | 1 556 055 | ||||
2014-11-12 | 2014-11-12 | 4 | Troendle August J. | CHRS | Warrant to Purchase Series B Preferred Stock | I | 0,02 | −107 528 | 0 | |||||
2014-11-12 | 2014-11-12 | 4 | Troendle August J. | CHRS | Common Stock, $0.0001 par value | I | 358 428 | 358 428 | ||||||
2014-11-12 | 2014-11-12 | 4 | Troendle August J. | CHRS | Common Stock, $0.0001 par value | I | 266 502 | 2 142 492 | ||||||
2014-11-12 | 2014-11-12 | 4 | Troendle August J. | CHRS | Common Stock, $0.0001 par value | I | 1 556 055 | 1 875 990 | ||||||
2014-11-12 | 2014-11-12 | 4 | Troendle August J. | CHRS | Common Stock, $0.0001 par value | I | 319 935 | 319 935 | ||||||
2014-11-12 | 2014-11-12 | 4 | Herman Alan C. By Trust | CHRS | Series B Preferred Stock | I | −5 224 | 0 | ||||||
2014-11-12 | 2014-11-12 | 4 | Herman Alan C. By Trust | CHRS | Series A Preferred Stock | I | −39 991 | 0 | ||||||
2014-11-12 | 2014-11-12 | 4 | Herman Alan C. | CHRS | Series B Preferred Stock | D | −1 503 | 0 | ||||||
2014-11-12 | 2014-11-12 | 4 | Herman Alan C. | CHRS | Series B Preferred Stock | D | −2 | 1 503 | ||||||
2014-11-12 | 2014-11-12 | 4 | Herman Alan C. | CHRS | Series B Preferred Stock | D | 0,0167 | 1 505 | 0 | 1 505 | ||||
2014-11-12 | 2014-11-12 | 4 | Herman Alan C. | CHRS | Warrant to Purchase Series B Preferred Stock | D | 0,02 | −1 505 | 0 | |||||
2014-11-12 | 2014-11-12 | 4 | Herman Alan C. | CHRS | Warrant to Purchase Common Stock | D | 1,67 | −239 952 | 0 | |||||
2014-11-12 | 2014-11-12 | 4 | Herman Alan C. By Trust | CHRS | Common Stock, $0.0001 par value | I | 5 224 | 300 164 | ||||||
2014-11-12 | 2014-11-12 | 4 | Herman Alan C. By Trust | CHRS | Common Stock, $0.0001 par value | I | 39 991 | 294 940 | ||||||
2014-11-12 | 2014-11-12 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 1 503 | 214 699 | ||||||
2014-11-12 | 2014-11-12 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | −26 756 | 213 196 | ||||||
2014-11-12 | 2014-11-12 | 4 | Herman Alan C. | CHRS | Common Stock, $0.0001 par value | D | 1,6670 | 239 952 | 400 | 239 952 | ||||
2014-11-12 | 2014-11-12 | 4 | LILLY ELI & CO By Group | CHRS | Series C Preferred Stock | I | −543 101 | 0 | ||||||
2014-11-12 | 2014-11-12 | 4 | LILLY ELI & CO By Group | CHRS | Series B Preferred Stock | I | −2 333 955 | 0 | ||||||
2014-11-12 | 2014-11-12 | 4 | LILLY ELI & CO | CHRS | Common Stock, $0.0001 par value | D | 13,5000 | 164 963 | 2 227 | 3 042 019 | ||||
2014-11-12 | 2014-11-12 | 4 | LILLY ELI & CO | CHRS | Common Stock, $0.0001 par value | D | 543 101 | 2 877 056 | ||||||
2014-11-12 | 2014-11-12 | 4 | LILLY ELI & CO | CHRS | Common Stock, $0.0001 par value | D | 2 333 955 | 2 333 955 | ||||||
2014-11-10 | 2014-11-06 | 4 | Satvat Ali J. | CHRS | Stock Option (Right to Buy) | D | 13,50 | 14 997 | 14 997 | |||||
2014-11-06 | 3 | Herman Alan C. By Trust | CHRS | Common Stock, $0.0001 par value | I | 509 898 | ||||||||
2014-11-06 | 3 | Herman Alan C. By Trust | CHRS | Common Stock, $0.0001 par value | I | 509 898 | ||||||||
2014-11-06 | 3 | HEALY JAMES | CHRS | Common Stock, $0.0001 par value | I | 269 946 | ||||||||
2014-11-06 | 3 | HEALY JAMES | CHRS | Common Stock, $0.0001 par value | I | 269 946 | ||||||||
2014-11-06 | 3 | Troendle August J. | CHRS | Common Stock, $0.0001 par value | D | 43 740 | ||||||||
2014-11-06 | 3 | Troendle August J. | CHRS | Common Stock, $0.0001 par value | D | 43 740 | ||||||||
2014-11-06 | 3 | Lanfear Dennis M | CHRS | Common Stock, $0.0001 par value | D | 1 460 706 | ||||||||
2014-11-06 | 3 | Lanfear Dennis M | CHRS | Common Stock, $0.0001 par value | D | 1 460 706 | ||||||||
2014-11-06 | 3 | Lanfear Dennis M By Revocable Trust | CHRS | Common Stock, $0.0001 par value | I | 2 768 445 | ||||||||
2014-11-06 | 3 | Lanfear Dennis M By Revocable Trust | CHRS | Common Stock, $0.0001 par value | I | 2 768 445 |